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Neuronal development starts after the closure of the neural tube when neural 
stem cells begin to divide asymmetrically at the ventricular zone of the 
forebrain. Newborn neurons then migrate vertically from the ventricular zone to 
the cortical plate to reach their destinations and start generating axons and 
dendrites. After completing neuronal migration, neurons further extend and 
branch axons and dendrites. In the final step of neuronal development, neurons 
establish neuronal networks by forming and refining chemical synapses 
through synaptogenesis and synapse elimination. These four developmental 
steps are spatially and temporarily regulated by multiple signaling pathways. 
Ubiquitination, which is a regulatory posttranslational modification, is one of the 
most crucial processes necessary for such complex synaptic formation. In this 
study, we demonstrate the roles of Nedd4 family E3 ubiquitin ligases in nerve 
cells and characterize substrate proteins contributing to the current 








The human brain is composed of ~10
12 neurons, each of which is connected 
with other neurons through 1000 synapses on average. Neuronal networks, 
composed of ~1015 synapses, play essential roles in the regulation of 
complex brain functions, including motor and cognitive functions. Neurons 
have a structure like none of the other cells in the body, with an extended 
axon and highly branched dendrites and are connected via synapses to 
other neurons. Thus creating uninterrupted neural connectivity, which 
makes the nervous system unique (Brose, 1999; Alberts et al., 2002). 
Addition of a small globular protein called ubiquitin to a substrate protein is 
named ubiquitination. It is a posttranslational modification, one of the most 
critical processes required for such complex synaptic formation. In this 
thesis, I explain how specific protein ubiquitination pathways regulate brain 
development and function.  
 
1.1. Neural development 
 
Development of neurons starts after the closure of the neural tube when 
neural stem cells begin to divide asymmetrically at the ventricular zone of 
the forebrain. Newborn neurons migrate vertically from the ventricular zone 
to the cortical plate to reach their destinations and start projecting axons and 
dendrites. After completing neuronal migration, neurons further develop 
arborization of axons and dendrites. In the final step of neuronal 
development, neurons establish neuronal networks by forming and refining 
chemical synapses through synaptogenesis and synapse elimination (Figure 






Figure 1.1. Neural development steps in mammalian brain. (A) The 
extension of in the basal protrusion of radial glial cells (RGCs) in the 
developing cortex. RGCs have the potential to turn into premature neurons, 
intermediate progenitors (IPs) and glial progenitors (oligodendrocytes and 
astrocytes). (B) RGCs produce premature neurons or basal progenitor (BP) 
cells upon asymmetric division. (C) As newly generated neurons migrate 
along RGC processes they receive a signal from Cajal–Retzius cells (shown 
in dark blue). Then they distribute throughout the cortical plate (i), and start 
to differentiate (ii). (D) Generation of the immature axon and immature 
dendrites. (E) Extension of the processes of neurons and generation of 
networks by synaptogenesis and synapse elimination (Modified from 
Kawabe and Brose, 2011, with license number 4575271327304). 
 
 
1.1.1. Neurogenesis  
The neural plate and neural tube are made up of a single layer of cells 
called neuroepithelial cells, which produce the neuroepithelium. During the 
cell cycle, interkinetic nuclear migration, the phenomena of up-and-down 
migration of nuclei inside neuroepithelial cells through the apical–basal axis 
occurs. Because of this process, the neuroepithelium looks like it is layered 
(pseudostratified). Neuroepithelial cells carry typical epithelial features and 
are polarized along their apical-basal axis. Tight junctions and adherence 
junctions are found at the apical end of the lateral plasma membrane. 
Specific transmembrane proteins such as prominin-1 (CD133) are 
selectively found in the apical plasma membrane, as well as receptors for 





Generation of neurons leads to the transformation of the neuroepithelium 
into a tissue with several cell layers. With the start of neurogenesis, 
neuroepithelial cells downregulate specific epithelial features followed by the 
appearance of astroglial markers. After that, neuroepithelial cells 
differentiate to radial glial cells. These cells exhibit both neuroepithelial and 
astroglial properties. Radial glial cells have more fate-restricted progenitors 
compared to neuroepithelial cells, and a big population of neurons in the 
brain originate from radial glial cells either directly or indirectly. 
Another type of neuronal progenitor called the basal progenitor originates 
from the mitosis of neuroepithelial and radial glial cells. Basal progenitors 
carry different characteristics from neuroepithelial and radial glial cells as 
they express different genes such as the non-coding RNA, SVET1, and 
genes encoding the transcription factors TBR2, CUX1, and CUX2 (Götz & 
Huttner, 2005).  
 
1.1.2. Neural migration 
 
Similar to other motile cells, migration of neurons occur in three steps; (i) 
leading edge extension, (ii) nuclear translocation, also known as 
nucleokinesis, and (iii) retraction of the trailing process. Migration starts with 
the extension of leading edges of the cell by filopodia and lamellipodia that 
explore the microenvironment. It is followed by nucleokinesis, which refers 
to transfer of nucleus to the leading process, which is critically regulated by 
microtubule cytoskeleton. Nucleokinesis is followed by retraction of the 
trailing process. Compared to the other cell types, only neurons produce 
defined cell patterns at the end of migration, which could be named as the 
fourth and final step of neuronal migration (Rouvroit & Goffinet, 2001). 
Reelin is synthetized in early-generated Cajal-Retzius cells in the marginal 
zone, and has been identified as a crucial protein for the correct alignment 
of cortical neurons (Honda et al., 2011). Neurons are generated close to 




recently produced neurons go through the same pathway, they end up 
closer to the marginal zone, and it leads to the formation of in an ‘‘inside-
out’’ pattern. In the end, firstly generated neurons settle at a deeper position 
and recently generated neurons are placed in a superficial position in the 
cortical plate. This migration process is determined by the Reelin signaling 
pathway. It has been shown that this alignment is completely altered in 
reeler mutant mouse lacking Reelin protein (Frotscher, 1998). 
 
 
1.1.3. Neuritogenesis: formation of axon and dendrites 
 
After creation and differentiation of neurons, neurons loose their symmetry 
by producing axons and dendrites, and generate two structurally and 
functionally distinct compartments. This process starts with generation of 
small protrusions, called neurites, and then they start polarizing and only 
one neurite turns to an axon, while the rest of neurites will develop to 
dendrites.  
There are four key steps maintaining neurite extension. 1) Increase in 
plasma membrane surface amount by vesicle recruitment and fusion. 
Amount of signaling molecules such as Rho GTPase and 
phosphatidylinositol 3-kinase (PI3K) are elevated, and they become 
activated. 2) Population of actin filaments are increased, 3) Then an 
increase in microtubule assembly. Even a small amount of microtubule 
growth also triggers an opposite reaction: diminish in microtubule as well as 
actin filament dynamics and increased endocytosis. 4) An extension-
retraction cycle is produced to have balanced positive and negative signals 
before polarization. When there is a positive cue occurring in this balance, 
continuous self-activation system (positive feedback loop) is activated, and 
generation of axon starts. This system also leads to strong negative 
feedback signals and blocks all other neurites from creating a second axon 





1.1.4. Synaptogenesis and synapse elimination 
Synapse formation is the last step in the development of a neuron. Synaptic 
junctions are asymmetric cell-to-cell contacts, which are composed of three 
components: presynaptic bouton, synaptic cleft, and postsynaptic spine. The 
presynaptic bouton has synaptic vesicles filled with neurotransmitters. 
Those vesicles dock at the presynaptic active zone and fuse with 
presynaptic plasma membrane to release neurotransmitter into the synaptic 
cleft. The presynapse is specialized for complex membrane trafficking in 
order to control neurotransmitter release with spatiotemporal precision. 
Directly opposed to the presynapse is the postsynaptic plasma membrane. 
The postsynaptic compartment is scaffolded by an electron-dense structure 
called the postsynaptic density (PSD) The PSD is responsible for 
accumulating and anchoring postsynaptic receptors and ion channels at a 
high density. The postsynapse is specifically developed for signal 
transduction, containing a complex structure of neurotransmitter receptors, 
ion channels, and a collection of intracellular signal transduction molecules 
(Garner et al., 2002).  
The complex structure of synapses is established in two steps, 
synaptogenesis and synapse elimination. Synaptogenesis starts with the 
initial contact between an axonal growth cone and a target cell. The growth 
cone targets a certain population of target cells via specific pairs of cell 
adhesion proteins. Following the initial contact, pre- and postsynaptic 
protein recruitment starts, and synapse asymmetry is maintained by trans-
synaptic signaling. After formation of immature synapses, a significant 
population of synapses is eliminated whereas some others are strengthened 
during brain development. This balance between synapse elimination and 
strengthening is regulated by synaptic activity, which plays a critical role for 
the establishment of proper neuronal networks that mediate learning and 






1.2. Structure of postsynapses 
Neuronal communication gives rise to numerous processes from basic to 
higher-order that are required for regular brain function. This communication 
is achieved at a specific and compartmentalized site of contact lying 
between a presynaptic nerve terminal and a postsynaptic neuron: the 
synapse. The presynaptic terminal transfers information via chemical 
message with the help of particular receptors in the postsynaptic membrane, 
where the received message is processed. Synapses are produced from the 
differential propagation and amount of particular presynaptic and 
postsynaptic proteins, which leads to explicit organization as well as 
appropriate function (Scannevin & Huganir, 2000; Südhof & Malenka, 2008).  
Glutamate is a neurotransmitter responsible for the majority of excitatory 
neurotransmission in the central nervous system with the help of several 
glutamate receptors; ionotropic receptors that consist of ion channels, and 
metabotropic receptors that are coupled to G proteins. Ionotropic glutamate 
receptors consist of three main subtypes depending on their 
pharmacological and electrophysiological characteristics and sequence 
homology: α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), 
kainate, and N-methyl-D-aspartate (NMDA) receptors. AMPA and kainate 
receptors mainly regulate fast electrophysiological responses to glutamate 
level. Additionally, NMDA receptors are regulated by calcium through the ion 
pore, therefore involved with synaptic plasticity (Paoletti et al., 2013). 
Metabotropic glutamate receptors on the other hand, relate glutamate 
release to G protein-mediated signaling cascades in the postsynaptic 
membrane. Moreover, in the postsynaptic density, there are multiple of PDZ 
domain containing scaffold proteins such as postsynaptic density protein 95 
(PSD-95), which coordinates glutamate receptors and related signaling 
proteins. PDZ domain containing proteins are key regulators controlling 
protein content and structure at the synapse, which are also affected by 
protein synthesis and degradation, as well as subcellular distribution and 




assembly and construction of the postsynapse (Kim & Sheng, 2004; 
Scannevin & Huganir, 2000). 
 
1.3. Overview of the brain structure  
The brain can be categorized into three main parts: the hindbrain, midbrain, 
and forebrain. Among them, the hindbrain is composed of the medulla, 
pons, and cerebellum, the midbrain is composed of tectum and tegmentum, 
and the forebrain is comprised of the diencephalon and cerebral 
hemispheres. Actions related to the cognitive abilities happen mainly in the 
cerebrum or cortex in the brain. Between the two hemispheres, the cortex 
can be separated into four anatomically defined lobes named as frontal, 
parietal, temporal, and occipital lobes. The cortex is the biggest part in the 
human brain that has been linked with higher brain functions like thought 
and action (Kandel et al., 2000).  
 
1.3.1. Structure of the hippocampus 
The hippocampus is located within the medial temporal lobe in the brain, 
forming the central part of the limbic system. The development and the 
function of neurons and synapses have been studied in this region, because 
of its relatively simple and well defined neuronal network pattern, which 
makes it possible to perform electrophysiological as well as morphological 
studies.  
The hippocampus is composed of the dentate gyrus and the Ammon’s horn 
field carrying four parts of the Cornu Ammonis 1-4 (CA1- 4). The laminar 
neuronal pathway called the trisynaptic loop is the basis of hippocampal 
neuronal circuit (Figure 1.2). Sensory information of neurons in layer II of the 
entorhninal cortex transfer excitatory input to the dendrites of granule cells 
through the perforant path (PP). Granule cells send projections to the 




Axons of CA3 pyramidal neurons project to ipsilateral CA1 pyramidal 
neurons by Schaffer collaterals and to contralateral CA3 and CA1 pyramidal 
cells by commissural connections. CA3 pyramidal neurons also receive 
direct input from layer II cells of the entorhinal cortex. Layer III cells of the 
entorhinal cortex excite the distal apical dendrites of CA1 pyramidal neurons 
(Neves et al., 2008; Deng et al., 2010).  
 
Figure 1.2. Illustration of the rodent hippocampus  a. An illustration of 
the hippocampal circuitry in rodents. b. Scheme of the hippocampal neural 
network demonstrating excitatory trisynaptic pathway (entorhinal cortex 
(EC)–dentate gyrus–CA3–CA1–EC) is shown by solid arrows. The axons 
from layer II neurons in the entorhinal cortex send projections to the dentate 
gyrus via the perforant pathway (PP), including the lateral perforant pathway 
(LPP) and medial perforant pathway (MPP). The dentate gyrus projects to 
the pyramidal cells in CA3 through mossy fibres. CA3 pyramidal neurons 
transfer information to CA1 pyramidal neurons via Schaffer collaterals. CA1 




the EC. CA3 neurons also receive direct projections from EC layer II 
neurons via the PP. CA1 neurons receive direct inputs from EC layer III 
neurons via the temporoammonic pathway (TA). The dentate granule cells 
also send projections to the mossy cells in the hilus and hilar interneurons, 
which send excitatory and inhibitory projections back to the granule cells 
(Deng et al., 2010, with license number 4575280057012). 
 
1.4. Roles of the hippocampus in memory formation  
 
In the adult brain, the hippocampus is a primary structure for the formation 
of specific kinds of memory such as episodic memory and spatial memory. 
Interactions of hippocampus with different brain structures linked with 
emotion also affect emotional behavior (Neves et al., 2008; Bird & Burgess, 
2008). Activity-dependent synaptic plasticity has a critical role in the 
production of synaptic connections, and it has been demonstrated several 
times that memory formation relies on alterations in synaptic efficiency that 
enables strengthening and weakening of neuronal connections (Lynch, 
2004). Synaptic plasticity is also responsible for the early development of 
neural circuitry, and disturbances in synaptic plasticity cause numerous 
neuropsychiatric disorders (Citri & Malenka, 2008). 
Memory formation can be divided into two forms: short-term memory lasting 
a few minutes, and long-term memory that lasts for some hours, days and 
even longer. The storage of long-term memory requires gene expression as 
well as de novo protein synthesis, leading to generation of new synaptic 
connections at the cellular level (Lynch, 2004). Interestingly, memory acts in 
parallel with long-term potentiation (LTP), which is a long-lasting change in 
synaptic strength that can be induced electrically by stimulating 
hippocampal afferents mimicking neuronal activity. The early phase of LTP 
(E-LTP) that takes 1-2 hours, is independent of protein synthesis, whereas 
the late phase or long-lasting LTP (L-LTP) that lasts for several hours in 




studied and the most easily observable in the hippocampus, depicting its 
crucial role in memory acquisition (Lynch, 2004; Bliss et al., 2018). 
 
1.5. Ubiquitination 
Ubiquitin (Ub) is a small globular protein composed of 76 amino acids. The 
process of conjugation of the C-terminal glycine residue of Ub to a lysine 
residue of the substrate is called ubiquitination. Ubiquitination is a post-
translational modification that results in several outcomes, such as protein 
degradation, endocytosis, DNA damage response, endoplasmic reticulum-
associated degradation, sorting and trafficking of transmembrane proteins. 
Ubiquitination is catalyzed by three classes of enzymes: ubiquitin-activating 
enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-ligating 
enzymes (E3s) (Hershko & Ciechanover, 1998; Akutsu et al., 2016). 
Conjugation of ubiquitin to a protein substrate starts with the formation of a  
thioester bond between the C-terminus of ubiquitin and an internal cysteine 
residue of the E1 enzyme at the expense of ATP-hydrolysis, followed by the 
shuttling of active ubiquitin onto a specific cysteine residue of one of E2s. 
E2s either transfer ubiquitin to a cysteine residue of an E3 or the E2-
ubiquitin conjugate forms a protein complex with an E3. E3s determine the 
substrate specificity of ubiquitination by directly or indirectly binding to a 
given set of substrate proteins. Ultimately, an isopeptide bond is formed 
which links the C terminus of ubiquitin to specific internal lysine residues of 
the substrate proteins (Figure 1.3). Deubiquitinases (DUB) reverse 
ubiquitination of substrates by cleaving the isopeptide bond in an ATP-
independent manner (Rape, 2017; Rotin & Kumar, 2009). 
The mammalian genome encodes a few E1, some dozens of E2 ligase, and 





Figure 1.3. Steps of ubiquitination. Protein ubiquitination is catalyzed in 
three main steps. Activation performed by E1 ubiquitin activating enzymes; 
conjugation, performed by E2 ubiquitin conjugating enzymes, and ligation 
performed by E3 ubiquitin ligases (E3) respectively. 
 
1.5.1. Types of ubiquitination 
Ubiquitin itself contains seven lysine (K) residues, K6, K11, K27, K29, K33, 
K48 and K63, each of which can serve as an acceptor of the active C-
terminal glycine residue to form polyubiquitin chains (polyUbs) (Figure 1.4) 
(Akutsu et al., 2016; Tai & Schuman, 2008). Characteristics of complex 
ubiquitination are not fully understood. The most studied polyubiquitin 
chains are K48-linked polyUbs. This chain type leads to degradation of the 
substrate protein by the 26S proteasome, whereas monoubiquitination as 
well as K63-linked polyUb chains have a role in transcriptional regulation, 
endocytosis, and kinase activation (Galan et al., 1997; Bach et al., 2003; 
Woelk et al., 2007). Ubiquitin molecules can also be further regulated by 
other post-translational modifications such as acetylation (Ohtake et al., 
2015) and phosphorylation (Kane et al., 2014; Kazlauskaite et al., 2014; 
Koyano et al., 2014; Ordureau et al., 2014; Swaney et al., 2015), revealing 







Figure 1.4. Structure of ubiquitin and its lysine residues. There are 
seven lysine residues (shown in red with blue nitrogen atoms) on different 
sides of the ubiquitin molecule. Met1 indicated with a green sulfur atom is 
the linkage point located close to Lys63. The C-terminal Gly75-Gly76 motif 
has a role in isopeptide bond formation (red oxygen atoms, blue nitrogen 
atoms). Red numbers in parentheses show the relative abundance 
(Komander, 2009, DOI: 10.1042/BST0370937). 
 
 
There are two main types of E3s: Really Interesting New Gene (RING) type 
and the Homologous to E6-AP C-terminus (HECT) type. RING E3s, which 
constitute the majority of E3s, transfer ubiquitin directly to the substrate by 
playing a scaffold role (Rotin & Kumar 2009). They share a CX2 CX9–39 
CX1–3 HX2–3 (C/H) X2CX4–48CX2C sequence that makes a crossbrace 
motif. When two zinc atoms bind via cysteine and histidine residues, the 
crossbrace motif is stabilized. HECT E3s, on the other hand, carry a 
conserved catalytic cysteine residue. Instead of direct transfer of ubiquitin, 
the conserved cysteine has a role as an ubiquitin acceptor from E2s. After 
this additional step, ubiquitin is then transferred to a lysine residue on the 




type E3 ligases can be categorized into three subfamilies, the Neuronally 
Expressed Developmentally Downregulated 4 (Nedd4) family, the HERC 




1.5.2. Nedd4 family E3 ligases 
The Nedd4 family of HECT-type ligases consists of 8 genes in the rodent 
genome and 9 genes in the human genome. Based on their homologies, 
they fall into four subfamilies; Nedd4-, Smurf- (Smad ubiquitin regulatory 
factors), Wwp-, and NEDL- (Nedd4 like) subfamilies. All of the Nedd4 
ligases have a common C2 domain in N-terminus that is involved in 
autoinhibition and subcellular localization of the ligase, two to four WW 
domains responsible for substrate recognition by interacting with PPXY 
(also called PY) motif on substrates, and a catalytic HECT domain that 
interacts with E2 to transfers ubiquitin to the cysteine residue at its catalytic 
center (Figure 1.5). Nedd4 family E3 ligases play crucial roles in many 
physiological processes such as cell proliferation and growth, development 
and cancer (Rotin & Kumar 2009). The first discovered physiological role of 
Nedd4-1 and Nedd4-2 dependent ubiquitination was found in the epithelial 
cells of the kidney tubules (Staub et al., 1996). It has been demonstrated 
that Nedd4-1 and Nedd4-2 regulate membrane levels of ENaC (epithelial 
sodium channel) via the binding of WW domains of Nedd4s to the PY motif 
of ENaC (Donovan & Poronnik, 2013; Yang and Kumar, 2010). 
Ubiquitination via Nedd4 family E3 ligases are mostly K63 specific, and a 
majority of them have been linked with neuronal development in many 









Figure 1.5. Nedd4 Family E3 ligases. Nedd4 family E3 ligases can be 
categorized into four subfamilies. Each of them has a conserved domain 
structures with a C2 domain in their N terminus mainly involved in 
autoinhibition and localization of the ligase, two to four internal WW domains 
which are responsible for substrate recruitment by interacting with PY motif 
on substrate proteins, and a HECT domain involved in E2 interaction and 




1.5.3. Nedd4 ligases in the brain 
 
Expression of Nedd4s start from early stages in mouse central nervous 
system, reaches to the highest level during neurogenesis, and decreases 
until adulthood. Nedd4-1 expression is found ubiquitously in the brain, 
whereas Nedd4-2 expression is more limited. Additionally, these two ligases 
have different substrate proteins although they share high homology (Anan 
et al., 1998; Kumar et al., 1997). 
 
Nedd4-1 and Nedd4-2 are essential genes. Both Nedd4-1 and Nedd4-2 
knockout (KO) mice are perinatally lethal. It has been shown that Nedd4-1 
KO mice show severe developmental retardation, and they are quite smaller 




Nedd4-2 KO mice do not have a change in size, and lethality occurs due to 
an ENaC-related lung phenotype (Boase et al., 2011; Cao et al., 2008; Shi 
et al., 2008).  
 
Given that Nedd4-1 and Nedd4-2 are both highly expressed during 
development, it has been supported with recent studies that Nedd4-1 and 
Nedd4-2 have critical roles in neuronal development like neurite outgrowth, 
axon guidance, neuronal survival, and cell fate determination. Zebrafish 
have only one Nedd4 gene, which plays a crucial role in the dorsoventral 
patterning of the neural ectoderm (Bakkers et al., 2005). Drosophila Nedd4 
regulates the cell fate by downregulating the Notch pathway (Dalton et al., 
2011; Sakata et al., 2004). Conditional Nedd4-1 KO mice have a reduction 
in dendrite branching (Kawabe et al, 2010). Nedd4-1 has also been 
characterized as a positive regulator of axonal growth in hippocampal 
neurons as a downstream of PI3K/PTEN/mTOR pathway (Hsia et al., 2014). 
In humans, the Nedd4-2 gene has found to be linked with seizures and 
photosensitive epilepsy (Zhu et al, 2017; Vanli-Yavuz et al, 2015). 
 
Nedd4-1 and Nedd4-2 also target several ion channels such as voltage-
gated sodium channels (Rougier et al., 2005), voltage-gate potassium 
channels (KCNQ) channels (Ekberg et al., 2007), and voltage-gated calcium 
channels (Rougier et al., 2011). Nedd4-2 also regulates the amount of 
plasma membrane glutamate transporters, such as EAAT, EAAT2 and 
EAAT3/4 (Sopjani et al., 2010). Protein kinase C (PKC) phosphorylates 
Nedd4-2, which enhances its association with and ubiquitination of EAAT2, 
resulting in endocytosis (Garcia-Tardon et al., 2012). PKC-dependent 
activation of Nedd4-2 has also been linked to regulation of dopamine 
transporters (Vina-Vilaseca & Sorkin, 2010). Likewise, Nedd4s target 
AMPA–type glutamate receptors. It has been shown in hippocampal 
neurons that ubiquitination of GluA1-containing AMPA receptors via Nedd4-
1 causes internalization of the receptor and translocation to the lysosome 
(Lin et al., 2011). Additionally, polymorphisms in Nedd4-1 and Nedd4-2 
have been linked with a number of diseases, such as hypertension (Van 




stroke recovery (Sang et al., 2006. Lackovic et al., 2012).  All together 




1.5.4. Ubiquitination and memory formation 
 
Learning and memory have been extensively studied using the Morris water 
maze (MWM) test, a test for spatial learning (Morris, 1984; Vorhees & 
Williams, 2010). There are several mutant mice with a gain- or loss-of-
function of genes involved in excitatory synaptic transmission showing 
enhanced memory formation, such as transgenic NR2B overexpressing 
mice (Tang et al., 1999; Wang et al., 2009), Cyclin-dependent kinase 5 
(Cdk5) conditional KO mice (Hawasli et al., 2007), transgenic p25 
overexpressing mice (Fischer et al., 2005), transgenic mice overexpressing 
neuron-specific motor protein kinesin family protein 17 (Kif17) (Wong et al., 
2002), opioid receptor-like-1 (ORL1) KO mice (Mamiya et al., 2003), 
transgenic mice overexpressing hepatocyte growth factor (Hgf) (Kato et al., 
2012), voltage-gate calcium channel β subunit (Cavβ3 KO) mice (Jeon et 
al., 2008), and D-amino-acid oxidase (Dao) KO mice (Maekawa et al., 2005)  
Not many studies have been reported regarding to ubiquitination and 
memory formation. There are only a few E3 ligase KO mice related with 
learning and memory, including E6-AP ubiquitin ligase (Ube3A) KO (Jiang et 
al., 1998), neuron specific anaphase promoting complex 2 (Apc2) 
conditional KO (Kuczera et al., 2001) and inducible reporter of the LDL 
receptor (IDOL) KO (Gao et al., 2017), all of them revealing impaired spatial 
learning, and there are no studies linking enhanced memory formation with 







1.6. Aims of the study 
Ubiquitination is one of the most crucial regulatory mechanisms necessary 
for neuronal functioning as well as fundamental cellular functions. In this 
study, we wanted to elucidate the roles of Nedd4 Family E3 ligases in the 
mouse brain, with the focus of synaptic plasticity since there is still not much 
known about the involvement of ubiquitination process in synapse and 
synaptic plasticity. In the first part, after identifying the substrate, we 
characterized the substrate through biochemical studies, and then focused 
on in vivo studies such as behavioral and electrophysiological analysis as 


























2. MATERIALS AND METHODS 
 
2.1. Animals 
Nedd4-1f/f and Nedd4-2f/f mouse lines were generated by Dr. Hiroshi 
Kawabe and Prof. Dr. Nils Brose (Kawabe et al., 2010). The NEX-Cre 
mouse line was created and provided by Dr. Goebbels and Prof. Dr. Klaus 
A. Nave (Goebbels et al,, 2006). The Prr7f/f mouse line was created and 
provided by Dr. Hrdinka and Prof. Dr. Michael Kreutz (Hrdinka et al., 2016). 
All animal experiments were performed in agreement with the guidelines for 
the welfare of experimental animals issued by the State Government of 
Lower Saxony (Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit (LAVES) and the Max Planck Society (proportional to 
National Institute of Health Guidelines). Permissions 33.9-42502-04-
13/1359, 33.19-42502-04-15/1954, and 33.19-42502-04-16/2173 were 
licensed. 
                                                        
2.2. Reagents  
2.2.1. Chemicals  
Table 1. Chemicals used in this study  
Acrylamide/N,N’-Methylene-bis-Acrylamide National Diagnostic 
Adenosine Triphosphate (ATP) Sigma-Aldrich 
Agarose (UltraPure agarose) Invitrogen 





BCA Protein Assay Reagent A & B Thermo 
Benzonase Sigma 
Boric Acid Merck 




Bromophenol blue Pierce 
CHAPS Biomol  
Comassie Brilliant Blue R250 BioMol  
Darbecco Modified Eagle’s Medium (DMEM) Gibco, Invitrogen 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich 
Dithiothreitol (DTT) Sigma-Aldrich 
DNA Ladder Mix Sample, GeneRuler Fermentas 
DPBS Gibco, Invitrogen 
dNTPs GE Healthcare 
Skim Milk Nestle 
ECL Detection Reagents I-II Amersham, GE Healthcare 
ECL Supersignal Thermo 
EDTA Merck 
Ethanol Sigma-Aldrich 
Ethidium Bromide (1% solution) Carl Roth 
Ethylene Glycol Tetraacetic Acid (EGTA) Sigma-Aldrich 
FastGreen  Sigma-Aldrich 
Fish Skin Gelatin (FSG) Sigma-Aldrich 
GelRed Biotium 
Glucose Sigma-Aldrich 
Glutathione (GSH) Sigma-Aldrich 
Glycerol Sigma-Aldrich 
Glycine Sigma-Aldrich 
Goat Serum Gibco, Invitrogen 
HEPES  Sigma-Aldrich 




Luria Broth (LB) Sigma-Aldrich 
Magnesium Chloride (MgCl2 6H2O) Sigma-Aldrich 
Methanol J.T. Baker 
N-Ethylmaleimide (C6H7NO2, NEM) Sigma-Aldrich 







Opti-MEM  Invitrogen 
Paraformaldehyde (PFA) Serva 
Poly-L-lysine (PLL) Sigma 
Phosphate Buffered Saline (PBS) PAA Laboratories 
Phenylmethylsulfonyl Fluoride (PMSF) Roche 
Protein Molecular Weight Standards Invitrogen 
Restriction Endonucleases New England Biolabs 
(NEB) RNase OUT Invitrogen 
Sodium Bicarbonate (NaHCO3) Merck 
Sodium Butyrate Merck 
Sodium Chloride Merck 
Sodium Deoxycholate Wako 
Sodium Dodecyl Sulfate (SDS) Gerbu 
Sodium Phosphate (NaH2PO4) Roche 
Sucrose Sigma-Aldrich 
Triton X-100 Roche 
Trizma base Sigma-Aldrich  
Trizol Thermo 
Tween 20 Sigma-Aldrich 






Table 2. Commercial enzymes used during this study  
Gateway LR Clonase Enzyme Mix Invitrogen 
Alkaline Phosphatase Roche 
DNaseI (RNase free) Roche 
Pfu Polymerase Stratagene 
SuperScript III Reverse Transcriptase Thermo 
SYBR Green PCR master mix Applied Biosystems 
T4 DNA Ligase Invitrogen 






2.2.3. Bacterial strains 
Table 3. Bacterial strains used in this study  
E. coli DH5α competent cells Thermo 
E. coli Electro10-Blue competent cells Stratagene 
E. coli XL-1 Blue competent cells Stratagene 
E. coli TOP10 competent cells Invitrogen 
 
2.2.4. Kits and apparatus 
Table 4. Kits and apparatuses used in this study  
PureLink Quick Plasmid Miniprep Kit Invitrogen 
PureLink HiPure Plasmid Midiprep Kit Invitrogen 
ZymoPURE Plasmid Miniprep Kit Zymo 
EndoFree Plasmid Maxi Kit Qiagen 
ZymoClean Gel DNA Recovery Zymo 
Quick RNA Mini Prep Kit Zymo 
Direct-zol RNA Mini Prep Plus Kit Zymo 
TOPO TA Cloning Kit Invitrogen  
LigaFast™ Rapid DNA Ligation System  
 
Promega 
BCA Protein Assay Kit Thermo 
QuickChange II Site-Directed Mutagenesis Kit  Stratagene 





2.2.5. Vector plasmids 
Table 5. List of vectors used in this study  
pCRII TOPO Invitrogen (K4620-01) 





Provided by Dr. Bekir Altas 




pEYFP HA Prr7 Bfr PDZ 
PY1  
Generated in this study 
pEYFP HA Prr7 Bfr PDZ 
PY2 
Provided by Rashi Goel 
pEYFP HA Prr7 Bfr PDZ 
PY1/2 
Generated in this study 
pFUMVW Provided by Dr. Hiroshi Kawabe 
pFUMVW-iCre Provided by Dr. Hiroshi Kawabe 
pCX::myrVenus Provided by Dr. Anna-Katerina Hadjantonakis 
pFUGW 
Provided by Dr. Inder M. Verma (Addgene 
#12263) 
pFUGW-iCre Provided by Dr. Richard L. Huganir 
BL544-hN4-2 WT Provided by Dr. Hiroshi Kawabe 
BL544-hN4-2 C/S (C885S) Provided by Dr. Hiroshi Kawabe 
 
2.2.6. Oligonucleotides 
Oligonucleotide primers were synthesized in the Max Planck Institute for 








34358 GACGAGTTCGAAGAGGATGC (qRT-PCR for Prr7, F) 
34359 GAGGGGCAACTGTGGTTC (qRT-PCR for Prr7, R) 
20495 
GCTTGCTGGTGAAAAGGACCTCTCGAAG (qRT-PCR for 
HPRT1, F) 
20496 
CCCTGAAGTACTCATTATAGTCAAGGGCAT (qRT-PCR for 
HPRT1, R) 
14539 ATGGTGAAGGTCGGTGTGA (qRT-PCR for GAPDH, F) 




9146 CTTCCTCCCTGGAGAAGAGC (qRT-PCR for b-actin, F) 
9147 ATGCCACAGGATTCCATACC (qRT-PCR for b-actin, R) 
33278 
GAATCGGACATGTCTAAGCCGGCGTGCTTCGAGGAGGCGGT
G (Mutagenesis of PY1 of Prr7, F) 
33279 
GCCATCAGCACCGCCTCCTCGAAGCACGCCGGCTTAGACAT
GTCCGATTC (Mutagenesis of PY1 of Prr7, R) 
33280 
CTGATGGCCGAGCCGCCGGCTCCCTTCAGCGAGGTGCTCA
CGGACAC (Mutagenesis of PY2 of Prr7, F) 
33281 
CGAGTGTCCGTGAGCACCTCGCTGAAGGGAGCCGGCGGCT




Table 7. List of primary antibodies used in this study  
Antibody Host 
Species 
Origin Usage and Dilution 
WB IHC ICC 
Actin Rabbit Sigma (Cat#AV40173; 
RRID:AB_1844540) 





Mouse Abcam (Cat# ab22609, 
RRID:AB_447192) 
 








1:1000 - - 
Drebrin1 Mouse Provided by Dr. Irina 
Majoul 
 
1:200 - - 
GFP Rabbit MBL (Cat# 598S, 
RRID:AB_591816) 
 
- 1:1000 1:1000 
GluA1 Rabbit SYSY (Cat# 182 003, 
RRID:AB_2113441) 
 




GluA2 Rabbit SYSY (Cat# 182 103, 
RRID:AB_2113732) 
 
1:1000 - - 
GluR2/3 Rabbit Milipore (Cat# 07-598, 
RRID:AB_11213931) 
 
1:1000 - - 
GluN1 Mouse SYSY (Cat# 114 011, 
RRID:AB_887750) 
 
1:1000 - - 
GluN2B Rabbit SYSY (Cat# 244 103, 
RRID:AB_10805405) 
 
1:500 - - 
HA (HA.11) Mouse Biolegend (Cat# 901515, 
RRID:AB_2565334) 
 
1:1000 - 1:500 
Nedd4-1 Mouse BD Biosciences (Cat# 
611481, 
RRID:AB_398941) 
1:250 - - 
Nedd4-2 Rabbit CST (Cat#4013; 
RRID:AB_1904063) 
1:1000 - - 
Nedd4-2 Rabbit SYSY (Cat#283003) - 1:2000 - 




1:500 - - 
PSD-95 Mouse  BD (Cat#610495; 
RRID:AB_397861) 
1:500 - - 
Transferrin Mouse  Invitrogen (Cat# 13-
6800, RRID:AB_86623) 
 
1:1000 - - 
Ubiquitin Rabbit  DAKO (Cat#Z0458; 
RRID:AB_2315524) 
1:1000 - - 
Ubiquitin 
(K63) 
Rabbit Merck Milipore (Cat#05-
1308; 
RRID:AB_1587580) 
1:100 - - 
Ubiquitin 
(K63) 




β-Tubulin Mouse Sigma (Cat# T4026, 
RRID:AB_477577) 
 
1:5000 - - 









Mouse  Goat HRP (Cat#1721011; 
11125936) 
BioRad WB, 1:2500 
Rabbit Goat HRP (Cat#1721019; 
11125143) 
 
BioRad WB, 1:2500 











































2.3. Molecular biology 
2.3.1. Bacterial transformation of plasmid DNA 
2.3.1.1. Chemical transformation 
Frozen DH5α chemical competent E. coli cells were thawed on ice and 18-
20 µl was transferred to a pre-chilled round bottom falcon tube. Cells were 
mixed with 1-2 µl of plasmid DNA and the mixture in the falcon tube was 
kept on ice for 30 minutes. The tube was placed in a waterbath adjusted to 
42oC for 30 seconds. After the heat shock, the tube was kept on ice for 3 
minutes. 700 ul  pre-warmed SOC media was added to the transformed 
E.coli, which was incubated with moderate shaking for 1-1.5 hour at 37°C 
for recovery. After that, the cells were centrifuged at 10,000 rpm using a 
microcentrifuge (Eppendorf 5417R) for 2 minutes, and the supernatant was 
discarded. The E.coli pellet was resuspended and cells were plated on 
appropriate selection agar plates and incubated overnight at 37oC. 
LB medium: 25 g Luria Broth (LB, Invitrogen) in 1 L distilled H2O, and 
autoclaved.  
SOC medium (reagents in final concentration): 20 mM glucose, 2% (w/v) 
tryptone (DIFCO), 0.5% (w/v) yeast extract (DIFCO), 10 mM NaCl, 2.5 mM 
KCl, 20 mM MgCl2, in ddH2O and autoclaved. 
LB agar plates: 15 g Bacto-agar (Invitrogen) in 1 L LB medium, and 




A vial (50 µl) of frozen XL-1Blue electro-competent E. coli cells was thawed 




transferred to a pre-chilled electroporation cuvette (0.1 cm, BioRad), and an 
electric pulse of 1.80 kV (E. coli pulser, BioRad) was applied. Immediately 
after the electroporation, bacterial cells were taken out of the cuvette. The 
following procedures are same as described in chemical transformation 
above in 2.3.1.1.  
 
 
2.3.2. Glycerol stock preparation 
E. coli culture transformed with a construct of choice was grown overnight. 
800 µl of culture was taken and mixed with 200 µl of 80% autoclaved 
glycerol, vortexed, and stored at -80oC as a stock. In order to grow a culture, 
a piece of frozen stock was picked using a pipette tip and transferred into LB 
medium with an appropriate antibiotic. 
 
2.3.3. Plasmid DNA purification  
Plasmid DNA was purified from bacteria according to manufacturer’s 
protocols using ZymoPURE Plasmid Miniprep Kit (Zymo), PureLink Quick 
Plasmid kits (Invitrogen), or Endo-free Plasmid Maxi Kit (Qiagen). Plasmid 
DNA was then air dried and resuspended in TE buffer or endotoxin free TE 
buffer.  
TE buffer: 10 mM Tris-HCl pH 7.4 (Sigma-Aldrich), 1 mM EDTA (Sigma-
Aldrich).  
 
2.3.4. Determination of DNA concentration  
After diluting DNA samples 1:100 with TE buffer, absorptions were 
measured at 260 and 280 nm wavelength using an UltraSpec 3100pro 
(Amersham) to define the concentration of DNA. OD260/OD280 ratio around 





2.3.5. DNA sequencing  
Sequencing of DNA was done by the DNA Core Facility of MPIem by using 
Applied Biosystems 373 DNA Sequencer.  
 
2.3.6. DNA digestion with restriction endonucleases  
DNA was digested by specific restriction endonucleases according to the 
instructions provided by New England BioLabs. Briefly, the appropriate 
amount of DNA was digested for 2-3 hours in the appropriate buffer and 
temperature conditions depending on the enzyme used.   
 
2.3.7. Agarose gel electrophoresis  
In order to analyze the size or purify isolated DNA or RNA samples, 
nucleotide samples were subjected to agarose gel electrophoresis in 1-2% 
agarose (UltraPure, Invitrogen) gel containing 0.1% GelRed (Biotium) or 
ethidium bromide. DNA or RNA fragments were then separated in TBE 
buffer at constant current (100-150 V), and imaged under UV-light (Intas) 
(254 or 314 nm). The approximate DNA size was estimated with Gene Ruler 
DNA Ladder Mix (Fermentas) that was loaded on the same gel.  
TBE buffer:  
50 mM Tris-Base, 50 mM Boric acid, 2 mM EDTA, pH 8.0 
 
2.3.8. Gel extraction  
Agarose gel electrophoresis was followed by extraction of interested DNA 
band with a surgical scalpel from the agarose gel followed by purification 
using ZymoClean Gel DNA Recovery Kit (Zymo) according to the 





2.3.9. DNA ligation  
After digestion, gel electroporation, and gel extraction of linear plasmid DNA 
and insert DNA, they were mixed in a molar ratio of 1:3 or 1:1, and ligation 
was performed according to the manufacturer’s protocols of LigaFast™ 
Rapid DNA Ligation System by adding 1 µl T4 DNA ligase and the ligase-
specific buffer in reaction volume of 10 µl with the presence of 0.5 µM ATP. 
The ligation reaction was kept at room temperature for 20 minutes. 
 
2.3.10. Polymerase chain reaction (PCR)  
Desired DNA fragments were amplified by PCR according to the 
manufacture’s protocol using Pfu DNA polymerase (Cloned Pfu Polymerase 
AD or Turbo Pfu Polymerase AD, Agilent Technologies). For genotyping 
PCR, Red-Taq DNA polymerase (Sigma-Aldrich) was used. Reactions were 
carried out on a Gene Amp 9700 PCR cycler (Applied Biosystems) or Peltier 
Thermal Cycler PTC-225 (MJ Research, Bio-Rad) with the conditions below:  
Step 1: 95°C for 3 min  
Step 2: 95°C for 30 sec 
Step 3: annealing temperature for 30 sec 
Step 4: 72°C for extension time (500 bp per 1 kb of DNA) (30-35 cycles from 
Step 2 to 4)  
Step 5: 72°C for 10 min 
Annealing temperatures, extension times, and cycle numbers were adjusted 
according to the expected length of the PCR product and melting 






2.3.11. TOPO-TA subcloning  
The PCR products were subcloned into pCRII-TOPO vectors by using 
TOPO TA cloning Kits (Invitrogen) according to the manufacturer’s 
instructions. 
 
2.3.12. Site-directed mutagenesis 
For mutagenesis of cDNA, QuickChange II Site-Directed Mutagenesis Kit 
(Stratagene) was used according to the manufacturer's protocol. Briefly, 
partially overlapping forward and reverse primers with a point mutation were 
designed. The entire plasmid DNA was amplified in 25 µl of reaction 
mixtures containing oligonucleotide primers, dNTPs, and Pfu DNA 
polymerase (Stratagene) in the appropriate reaction buffer. PCR was carried 
out with the following protocol: 
Step 1: 95ºC for 3 min 
Step 2: 95ºC for 30 sec 
Step 3: 65ºC for 1 min 
Step 4: 72ºC for 3 min (5 cycles from Step 2 to Step 4) 
Step 5: 95ºC for 30 sec 
Step 6: 60ºC for 1 min 
Step 7: 72ºC for 3 min (5 cycles from Step 5 to Step 7) 
Step 8: 95ºC for 30 sec 
Step 9: 55ºC for 1 min 
Step 10: 72ºC for 3 min (30 cycles from Step 8 to Step 10) 
Step 11: 72ºC for 10 min 
Next, the PCR product was incubated with 1-2 µl of DpnI at 37ºC for 2 hours 
to digest the template plasmid. Chemical competent E. coli was transformed 
with the PCR product. Plasmid DNAs amplified and purified from single 





2.3.13. Isolation of genomic DNA from mouse tail biopsies  
For isolation of genomic DNA from mouse tail samples, Nexttec genomic 
DNA isolation kit was used according to the manufacturer’s protocol 
(Nexttec). 
 
2.3.14. Mutant mouse genotyping   
Genotyping of mutant mice was assessed in the DNA Core Facility of MPI-
EM by using PCR using oligonucleotide primers listed below (Wt, wild type 
allele; Cre, knock-in allele with Cre). 
 
Table 9. Genotyping information of mouse lines used in this study 
Mouse line Primers PCR product size 
NEX1-Cre 2409/3131/3132 Wt: 750 bp, Cre: 550 bp 
Nedd4-1
f/f
 10906/10907 Wt: 200 bp, Cre: 300 bp 
Nedd4-2
f/f
 12804/12806 Wt: 200 bp, Cre: 300 bp 
Prr7f/f 37556/37557 Wt: 274 bp, Cre: 420 bp 
 
All genotyping PCRs were performed with the following protocol:  
Step 1: 96°C for 3 min 
Step 2: 94°C for 30 sec 
Step 3: 64°C for 1 min 
Step 4: 72°C for 1 min (32 cycles from Step 2 to 4) 




2.3.15. RNA isolation 
 
Instruments used for RNA isolation were cleaned with 70% ethanol (Sigma) 
and RNA-Zap (Thermo Fisher) before starting the experiment. Brain tissue 
was collected from mice and flash-frozen in liquid nitrogen. It was followed 
by homogenization in 600-1000 µl of Trizol (Thermo Fisher) in 2 ml plastic 
tubes by using a Ultra Turrax homogenizer (IKA Labtechnik) for 40 seconds 
and incubated at room temperature for 3 minutes. Samples were centrifuged 
at 10,000 rpm using a microcentrifuge for 2 minutes. Supernatants were 
transferred to clean tubes and mixed with equal volumes of EtOH. Solutions 
were applied onto Zymo Spin Columns to concentrate RNA on the beads 
matrix (Direct-zol, RNA MiniPrep Plus, Zymo) and RNA was eluted by 
adding appropriate amount of buffer according to the manufacturer's 
protocol. 
 
2.3.16. Measuring RNA concentration  
RNA concentrations were estimated with a NanoDrop 2000c 
spectrophotometer (Thermo) by dropping 1 µl of the sample onto the 
measurement pedestal. OD260/OD280 ratio around 2 was accepted as a pure 
sample. 
 
2.3.17. cDNA synthesis  
cDNA was synthesized from purified RNA with the SuperScript III First-
Strand Synthesis System (Invitrogen) according to manufacturer's manual 
using anchored oligo(dT)20 and random hexamers. For each reaction, 1 µg 
of total RNA was used. After terminating the reaction by incubation at 85°C 







2.3.18. Real time quantitative reverse transcription PCR (qRT-PCR)  
qRT-PCR for cDNA synthesis and quantification was performed in 384 well 
plates (Roche). For each gene, a master mix was prepared with the 
presence of 5 µl of SYBR Green (Invitrogen), 0.1 µl of each primer, and 1 µl 
molecular biology grade H2O. 4 µl of cDNA sample was mixed with 6 µl of 
master mix into each well. All procedures were performed on ice, and 
exposure to room light was minimized. The plate was centrifuged at 1000 g 
for 5 minutes and put in the Light Cycler 480 (Roche Applied Science) with 
the following protocol. Primer information was given in Table 6.  
 
Pre-incubation 
Step 1: 95°C for 10 min  
Amplification 
Step 2: 95°C for 10 sec 
Step 3: 60°C for 30 sec 
Step 4: 72°C for 1 min (45 cycles from Step 2 to 3) 
Cooling 
Step 5: 40°C for 10 sec 
 
Samples were run as triplicates for each gene of interest, and if the cycle 
number to reach the threshold cycle is 5% more or less than other two 
duplicates, the value was excluded as an outlier. Relative levels of amplified 
products were normalized to levels of housekeeping genes, GAPDH, 
HPRT1 and beta-actin. The translational efficiency was calculated according 






2.4. Cell biology 
2.4.1. Media and solutions  
10%  FCS/DMEM 
500 ml DMEM, 50 ml FCS, L-Glutamine (Invitrogen, Cat#25030081), 5 ml 
Penicillin/Streptomycin (100x, Invitrogen, Cat#10378016). 
Complete Neurobasal Medium 
500 ml Neurobasal A, 5 ml GlutaMAX I (Invitrogen, Cat#35050061), 10 ml 
B-27 supplement (Invitrogen, Cat#17504044), 1 ml Penicillin/Streptomycin 
(100x, Invitrogen). 
Papain Solution 
20-25 units of Papain (Worthington) were added to 1 ml of Dulbecco’s 
Modified Eagle’s Medium (DMEM, Gibco, Life Technologies, 
Cat#41965039) supplemented with 0.1 mg/ml cysteine, 1 mM CaCl2, and 
0.5 mM EDTA. After resolving papain by bubbling with carbogen (95% 
oxygen, 5% carbon dioxide) for 10-20 min, the solution was sterilized using 
a 0.22 µm filter (Millipore, Cat#GSWP04700). 
Stop Solution 
2.5 mg/ml BSA, 2.5 mg/ml trypsin inhibitor, 10% FCS in DMEM. The 
solution was pre-warmed at 37°C before use. 
HEK cell medium 
500 ml DMEM, 50 ml FBS, 5 ml GlutaMAX, 5 ml Penicillin/Streptomycin. 
 
2.4.2. Treatment of coverslips for culturing primary neurons  
Coverslips (Menzel-Gläser) were incubated with 1 M HCl for 16-20 hours, 
rinsed with dH2O, treated with 70% ethanol, and rinsed again with dH2O. 
They were put in cell culture dishes under the fume hood and exposed to 




incubated with poly-L-lysine (Sigma-Aldrich, Cat#A-005-C) diluted 1:10 in 
DPBS (Gibco, Life Technologies, Cat#14190-044) at least for 2 hours at 
37°C in order to provide adhesion to the neurons. Later, coverslips were 
washed with PBS three times, and incubated with Complete Neurobasal 
medium at 37°C until seeding of neurons.  
 
2.4.3. Primary mouse neuron culture preparation 
For primary cortical neuron culture, cortices of E16 mice; for primary 
hippocampal neuron culture, hippocampi of P0 mice were dissected in ice-
cold HBSS under a stereomicroscope and incubated with 1 ml of papain 
solution in 1.5 ml plastic tube at 37°C with gentle agitation. After 1 hour of 
incubation, the papain solution was removed and tissues were incubated 
with the pre-warmed stop solution at 37°C for 20 minutes with mild shaking. 
The stop solution was removed and brain tissues were triturated in 200 µl 
pre-warmed complete Neurobasal medium by pipetting up and down for 20 
times. The tube was kept a while to settle the debris down, and isolated 
neurons in the supernatant were transferred into 1 ml of complete 
Neurobasal medium. The number of cells was estimated using a Naubauer 
counting chamber. 30,000-60,000 cells per cm2 were plated for 
immunocytochemistry and 120,000-300,000 cells per cm2 were seeded for 
biochemical experiments. The day that culture is prepared was counted as 
day in vitro 0 (DIV0). Neurons were kept in 500-1000 µl of complete 
Neurobasal medium per each well of 24-well plate at 37°C with 5% CO2 
(HERA-cell240 incubator, Heraeus). After keeping neurons for 2-3 hours in 
the seeding medium, it was changed to fresh complete Neurobasal medium 








2.4.4. HEK293FT cell line 
HEK293FT cells (Invitrogen, Cat#R70007; RRID:CVCL_6911) were cultured 
on 15 cm Petri dishes (Corning) in 20 ml of 10% FBS/DMEM at 37°C with 
5% CO2 (HERA-cell240 incubator, Heraeus). For passaging, confluent cells 
were washed with PBS, incubated with 1 ml of 0.05% Trypsin solution 
(Gibco, Life Technologies, Cat#25300054) for 3-5 minutes at 37°C. 9 ml of 
the fresh medium was added to stop trypsinization and then the cells were 
plated on new Petri dishes for the purpose of biochemical experiments or 
lentivirus production.  
 
2.4.5. Lentivirus preparation 
1.6 X 107 HEK293FT cells were plated on two poly-L-Lysine coated 15-cm 
plastic dishes and cultured for 24 hours in 10% FBS/DMEM until confluency, 
and cells on two plates were passaged onto five poly-L-lysine coated 15 cm 
plates in order to have the confluency of 80-90%. On the next day, the 
media was changed to 20 ml of pre-warmed 10% FBS/OPTI-MEM. The cells 
were co-transfected with 40 µg of lentivirus backbone vector [i.e. FUGW, 
FUGW-iCre, BL544-hN4-2 WT, or BL544-hN4-2 C/S] with 16 µg of plasmids 
encoding Gag polyprotein (pCMVdeltaR8.2; Addgene plasmid # 12263 ; 
http://n2t.net/addgene:12263 ; RRID:Addgene_12263) and envelope protein 
(pMD2.G; Addgene plasmid # 12259 ; http://n2t.net/addgene:12259 ; 
RRID:Addgene_12259), using Lipofectamine2000 according to the 
manufacturer's protocol. Cells were kept in 37°C incubator with 5% CO2. 
After 8-16 hours, the media was changed to 20 ml of pre-warmed 2% 
FBS/Sodium Butyrate (10 mM)/DMEM. 48 hours after transfection, culture 
medium was harvested in 50 ml Falcon tubes and centrifuged at 1000 g at 
4°C for 5 min to remove the debris. Supernatant was filtered using 45 µm 
filters (Millipore, Cat#HAWp04700) and loaded to AMICON Centrifugal Filter 




concentrate the virus. The final volume of the lentivirus solution was 
adjusted to 1 ml per 15 cm petri dish, and the aliquots were frozen in liquid 
nitrogen to store at -80°C for further use.  
 
2.4.6. Lentiviral infection of neurons  
After preparation, the virus solution was applied to cultured neurons at the 
stage of DIV0 or DIV1. At DIV7, after washing four times with PBS, neurons 
were fixed, and used for further staining experiments. The titer of virus 
solution was determined by counting the relative number of GFP- or dsRed-
expressing cells in all DAPI- and MAP2-positive cells. 
 
2.4.7. Immunocytochemistry  
Cells cultured on coverslips were fixed with 4% paraformaldehyde 
(PFA)/PBS for 15 minutes at 4ºC, followed by washing with PBS three 
times. Residual active PFA was quenched by incubation with 1mg/ml NaBH4 
for 5 minutes. Coverslips were washed with PBS three times and incubated 
with blocking buffer at room temperature for 1 hour. Next, samples were 
incubated with primary antibodies diluted in blocking buffer for 16-20 hours 
at 4ºC with gentle shaking. Coverslips were washed 3 times with PBS, and 
incubated with secondary antibodies for 1 hour at room temperature. After 
washing 3 times with PBS, coverslips were rinsed with dH2O and mounted 
onto microscope glass slides (MENZEL-GLASER, Cat#6310108) with 
Immu-mount mounting medium (Thermo Scientific, Cat#10662815). 
Immunostained cells were imaged with Zeiss Axio Imager Z1 epiflorescence 
or Leica SP2 confocal microscopy. 
Blocking buffer: 10% goat serum (Gibco, Life Technologies, Cat#50062Z), 
0.3% Triton X-100 (Roche, Cat# 11332481001), 5% sucrose, 1% BSA 






2.5.1. Homogenization of mouse brain 
Mice were anesthetized with isoflurane (CP pharma) and decapitated. 
Cortices or hippocampi were dissected; tissues were homogenized with 10 
strokes at 1200 rpm (Braun POTTER’S Homogenizer) in 1 ml Solution A 
using a Teflon-glass homogenizer (Sartorius) at 4ºC. The sample was left 
on ice for 3 min and procedure was repeated once more. 
Solution A: 0.32 M Sucrose, 1 mM NaHCO3, 10 µg/ml Aprotinin, 1 µg/ml 
Leupeptin, 100 µM PMSF 
 
 
2.5.2. Harvesting neuron culture 
For biochemistry, neurons in one well of the 24-well plate were washed 
three times with PBS, and then were harvested by adding 60 µl of Laemmli 
Buffer supplemented with 250 units of Benzonase and 5 mM MgCl2 
(Laemmli, 1970). 
Laemmli Buffer: 10% Glycerol, 50 mM Tris-Cl pH 6.8, 2 mM EDTA, 2% 
SDS, 100 mM DTT, 0.05% Bromophenol blue  
 
2.5.3. Estimation of protein concentration 
In order to quantify protein concentration, the bicinchoninic acid (BCA) 
method was used. After the reaction with the BCA regents (BCA assay kit, 
Thermo Piece, Cat#23225) according to the supplied protocol, absorbance 
value for each sample was measured at 652 nm. The protein concentration 





2.5.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Proteins were separated based on their molecular size by SDS-PAGE under 
denaturing conditions (Summers et al., 1965). An SDS-PAGE gel was 
prepared using the Bio-Rad Mini-PROTEAN 251 or in-house made casting 
system. 10-50 µg of the protein sample was loaded by using a syringe 
(Hamilton Bonaduz) along side with PageRuler or PageRuler Plus 
Prestained Protein Ladders (Thermo Scientific, Cat#26616, Cat#26619). 
 
Upper stacking gel: 
5% acrylamide/N,N’-Methylene-bis-Acrylamide (29:1) Solution (AMBA), 125 
mM Tris-HCl (pH 6.8), 0.1% SDS, 0.05% ammonium persulfate (APS), 
0.005% TEMED 
Lower separating gel: 
8-15% AMBA, 325 mM Tris-HCl (pH 8.8), 0.1% SDS, 0.05% APS, 0.005% 
TEMED 
Running buffer: 
25 mM Tris-HCl, 250 mM Glycine, 0.1% SDS (pH 8.8) 
 
2.5.5. Western blotting 
After SDS-PAGE, proteins in the gel were electrophoretically transferred 
onto a nitrocellulose membrane (Amersham Protran, 0.2 µm NC, GE 
Healthcare) in between 2 Whatmann papers (GE Healthcare Life Sciences) 
in transfer buffer with a constant current of 100 mA for 12 hours in a tank-
blotting unit (Towbin et al., 1979). Then, to stain transferred proteins, the 
membrane was stained in Ponceau or Memcode solution (Pierce, Thermo, 
Cat#24580). The membrane was washed and incubated with the blocking 
buffer for 45-60 min to prevent non-specific binding of antibodies to the 




antibodies listed in Table 7 for three hours at room temperature with 
moderate agitation in blocking buffer with the presence of Tween. The 
membrane was washed three times with TBS-T, and further incubated with 
secondary antibodies conjugated with horseradish peroxidase (HRP) or 
fluorophores (Table 8) for 45-60 min. After removing nonspecifically bound 
secondary antibodies by washing with TBS-T three times, the signal on the 
membrane was developed with enhanced chemiluminescence (ECL) 
system (Solution I and II, GE Healthcare) on X-ray films (Amersham 
Hyperfilm ECL, GE Healthcare) or detected with Odyssey CLx Infrared 
Imaging System (LI-COR Biosciences). Quantification of protein band 
intensities was assessed via the Image-Studio Software (Odyssey System) 
or ImageJ. 
 
Transfer buffer: 25 mM Tris-base, 190 mM Glycine, 20% (w/v) methanol  
TBS: 10 mM Tris-HCl, 150 mM NaCl, pH 7.5 
TBS-T: TBS, 0.1% Tween-20 
Ponceau Solution: 0.1% (w/v) Ponceau S, 5% (v/v) Acetic acid 
Blocking buffer: 5% (w/v) skimmed milk (Frema), TBS. 
Blocking buffer for phosphorylated antibodies: 5% (w/v), TBS. 
 
2.5.6. Purification of recombinant GST-fused proteins 
GST gene fusion system (GE Healthcare Life Sciences) was employed to 
purify GST-fused recombinant proteins. The cDNA fragment encoding the 
full-length N4-2 was subcloned into a pDEST15 vector, and back-
transformed into BL21 Rossetta E.coli strain. A single colony was picked 
and the E.coli were inoculated in 50 ml LB medium supplemented with 




transferred into 1 liter of LB media including ampicillin and incubated again 
until the optical density at 600 nm (OD600) reached 1. Then, expression of 
the GST fusion proteins was induced with 0.5 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG) for 6 hours at 20ºC. Cells were harvested by 
centrifugation at 3500 g at 4ºC for 30 minutes. The pellet was washed with 
PBS and resuspended in 50 ml of resuspension buffer. 5 ml aliquots of cell 
suspension were flash frozen in liquid nitrogen and kept at -80ºC for further 
usage. 
For further purification, aliquots were thawed by soaking in warm water and 
ice sequentially and supplemented with protease inhibitors (10 µg/ml 
Aprotinin, 1 µg/ml Leupeptin, 100 µM PMSF), 1 mg/ml lysozyme, and 0.05 
mg/ml DNase. Then, the cell suspension was sonicated for 20 seconds on 
ice, and an equal volume of resuspension buffer containing 2% CHAPS was 
added to solubilize the proteins. After 30 min incubation at 4ºC, the insoluble 
fraction was removed by centrifugation at 10,000 g for 10 min at 4ºC and the 
supernatant was harvested as the starting material of GST-fused protein. 
850 µl the supernatant was incubated with 50 µg of Glutathione (GSH) 
Sepharose beads (GE Healthcare, Cat#17-0756-01) according to the 
manufacturer’s instructions. After washing 3 times with wash buffer, the 
bound fractions of GST-fusion proteins were eluted with 40 mM reduced 
GSH. 
 
Resuspension buffer: 50 mM Tris-HCl (pH 8), 500 mM NaCl, 5 mM NaCl2,  
5 mM DTT, 10 µg/ml  Aprotinin, 1 µg/ml Leupeptin, 100 µM PMSF 
Wash buffer: 50 mM Tris-HCl (pH 8), 500 mM NaCl, 1% CHAPS, 5mM DTT  
  
2.5.7. Protein extraction from HEK293FT cells 
For the production of recombinant substrate proteins, HEK293FT cells were 
split and plated in 6 cm dishes as described in section 2.4.4, and transfected 
with HA tagged Prr7-expression vectors. 48 hours after transfection, cells on 




1 µg/ml Leupeptin, 100 µM PMSF) and frozen at -80ºC. After thawing cells 
at room temperature, cells were lysed by incubating with 500 µl of lysis 
buffer containing 0.5% SDS at 65ºC for 15 min. Samples were centrifuged 
at 16,000 g for 30 min and 500 µl of the supernatant was diluted with 4.5 ml 
of 0.5% Triton X-100 containing Lysis buffer so that SDS concentration was 
reduced to the level below the critical micelle concentration.   
 
Lysis buffer: 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 150 mM NaCl, 5 mM 
MgCl2, 2 mM DTT, 10 µg/ml Aprotinin, 1 µg/ml Leupeptin, 100 µM PMSF, 
250 units of Benzonase 
 
2.5.8. In vitro binding assay  
50 µg of the purified GST-N4-2 was immobilized on 50 µl glutathione 
Sepharose beads, which were subsequently equilibrated with five bed 
volumes of binding buffer. Recombinant substrate proteins extracted from 
HEK293FT cells in 2.5.7 were loaded on glutathione Sepharose beads and 
the beads were washed with five bed volumes of binding buffer to remove 
non-specifically bound proteins. Proteins bound on the beads were eluted 
with 200 µl of Laemmli buffer, and HA-tagged substrates in the eluate were 
detected by Western blotting using anti-HA antibody.  
Binding buffer: 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 150 mM NaCl, 2 mM 
DTT, 1% Triton X-100 
 
2.5.9. In vivo ubiquitination assay  
Cell based ubiquitination assay was performed by expressing substrate, E3 
ligase, and ubiquitin in HEK293FT cells using Lipofectamine2000 
(Invitrogen, Cat#11668019). After 48 hours of incubation, cells were washed 




thawed on ice, and by using a scraper, lysates were harvested with 200 µl 
ubiquitination lysis buffer in 2 ml plastic tubes and boiled at 65ºC for 20 min. 
1.8 ml Dilution buffer was added and SDS was neutralized and followed by 
centrifugation at 10,000 rpm for 10 min at 4ºC. Substrate was then 
immunoprecipitated using the anti-HA beads (Roche). After washing three 
times with washing buffer, beads were harvested with Laemmli Buffer 
containing DDT for SDS-PAGE and Western blotting. 
NEM: 125.6 mg NEM in 1 ml 100% Ethanol  
20 mM NEM/PBS: 1ml of NEM in 50 ml ice-cold PBS  
Ubiquitination Lysis Buffer: 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 1% 
SDS, supplemented with 250 units of Benzonase and 5 mM MgCl2 
Dilution Buffer: Ubiquitination Lysis Buffer with 1.11% Triton X-100 
Washing Buffer: Ubiquitination Lysis Buffer with 1% Triton X-100 
 
2.5.10. Biotinylation assay in primary cultured neurons 
High-density neurons (500,000-1,000,000 cells) were plated and infected 
with viruses EGFP and EGFP-Cre at DIV1. At DIV15, cells were washed 
with ice cold PBS, and incubated with Biotin (Thermo, Cat#21331, 1mg/ml 
Biotin in Tyrode’s working solution) for 20 minutes at 4°C with a gentle 
shake in every 5 minutes. Cells were quenched with 30 mM ammonium 
chloride, followed by a single TBS wash, then harvested with RIPA buffer 
supplemented with inhibitors by using a cell scraper. The cell lysate was 
rotated at 4°C for 10 min and centrifuged at 12,000 rpm for 15 min at 4°C. 
The supernatant was collected and protein concentrations were measured 
by the BCA method (Thermo). Equal amounts of control and N4-2 KO 
samples were incubated with streptavidin beads overnight at 4°C to capture 
biotinylated proteins. After spinning down and extensive washing of the 
beads, biotinylated proteins were harvested with Laemmli Buffer containing 




TBS: 20 mM Tris-HCl, 150 mM NaCl, pH 7.5 
RIPA buffer: 20 mM Tris-HCl, 150 mM NaCl, pH 7.5, 1% Triton X-100, 0.5% 
Sodium deoxycholate, 0.1% SDS, 10 µg/ml Aprotinin, 1 µg/ml Leupeptin, 
100 µM PMSF, phosphatase inhibitor (PhosStop, Roche, Cat#4906845001) 
 
Tyrode’s solution: 140 mM NaCl, 2.4 mM KCl, 10 mM HEPES, 10 mM D-
+glucose monohydrate, 2 mM CaCl2, 1.25 mM MgCl2, pH 7.6 
 
2.5.11. Subcellular fractionation of mouse brain 
 
Cortices of 6 week-old mice were dissected with ice cold Solution A (0.32 M 
Sucrose, 1 mM NaHCO3, Aprotinin, 1 µg/ml Leupeptin, 100 µM PMSF, 
phosphatase inhibitor (PhosStop, Roche) on ice and stored at -80°C until 
further use. Cortices from one mouse were homogenized in 3 ml Solution A 
with 10 strokes at 12,000 rpm with a Teflon-glass homogenizer, and 
homogenates were loaded on the top of a discontinuous sucrose density 
gradient with 0.85 M, 1.0 M and 1.2 M sucrose layers. Samples were 
centrifuged at 82,500 g for 2 hours at 4oC (SW41 rotor, Beckman Coulter) 
for fractionation. The fraction above the 0.85 M sucrose was harvested as 
the supernatant fraction (S), and the interphase between 1.0 M and 1.2 M 
sucrose layers harvested as the synaptosome fraction (P2C). The P2C 
fraction was diluted with Solution A and centrifuged at 32,800 g for 20 min 
(TLA100.3 rotor, Beckman Coulter). The pellet was resuspended in 2.4 ml of 
6 mM Tris-Cl, pH 8.0 using 21G and 27G needles (Becton Dickinson), and 
incubated for 45 minutes on ice for osmotic shock. Next, samples were 
centrifuged again at 32,800 g for 20 min (TLA100.3 rotor). The supernatant 
was harvested as synaptic cytoplasm and crude synaptic vesicle fractions, 
and the pellet was resuspended in 250 µl 6 mM Tris-Cl, pH 8.0 as the crude 
synaptic membrane (CSM) fraction using 21G and 27G needles. 
Subfractions were subjected to Western blotting for PSD-95 and Rab-GDI 





2.6.1 In utero electroporation (IUE)  
2.6.1.1 Preparation of glass capillaries 
Micropipettes were prepared from 1.5-1.8 X 100 mm borosilicate glass 
capillaries (Kimble and Chase) by HEKA PIP5 temperature controlled 
pipette puller. The filament of was heated approximately to 1200°C, and the 
speed to pull the glass capillary was controlled manually to get slow 
expansion of heated glass.  
 
2.6.1.2 Preparation of plasmid DNA for IUE 
Plasmid DNA was purified with EndoFree Plasmid Maxi Kit (Qiagen) and 
final DNA concentration was adjusted to 1.5 µg/µl with endotoxin-free TE 
buffer. Plasmid DNA was mixed with 0.1% Fast Green FCF (Sigma-Aldrich) 
to monitor the amount of plasmid solution injected to the lateral ventricle. 
DNA mixture was loaded into the microcapillary by using microloader pipette 
tips, and the tip of the microcapillary was cut with fine forceps to have the 
liquid flowing. 
 
2.6.1.3. Procedure   
E14.5 mouse embryos were subjected to IUE based on previously published 
work (Saito & Nakatsuji, 2001, Matsui et al., 2011, dal Maschio et al., 2012). 
Briefly, the pregnant mouse was deeply anesthetized by inhalation of 
isoflurane/oxygen, and placed on a warm heating pad (32°C) during the 
surgery. Before the surgery, the loss of toe pinch-reflex was checked to be 
able to continue with the surgical procedure. Vidisic gel (Bausch and Lomb) 
was applied onto each cornea to avoid any damage. A 2 cm incision of the 
abdominal cavity was made and embryos within the uterus were exposed, 




and 2 mg/ml streptomycin (Gibco). In brief, a glass micropipette was filled 
with 0 DNA Fast Green mixture and injected into the lateral ventricle of the 
brain of the pups by applying pressure using a pneumatic pump (PV820), 
followed by an electric current applied with ElectroSquare Porator 
(ECM830BTX Harvard Apparatus) for 50 ms with 950 ms interval via a 
homemade forceps-type electrode. The uterus with embryos was put back 
to the abdomen, and closed with absorbable surgical sutures (Safil, 
Aesculap; 4/0, 28’’; HR17), and the skin with 9 mm Autoclips (Clay Adam). 
For the pain management after operation, 3 mg buprenorphine (Temgesic) 
was given to the mouse subcutaneously. After the operation, the mouse was 
kept on the warm pad until it regained consciousness, and then monitored 
regularly. 
 
2.6.2. Perfusion  
Perfusion with 4% PFA in PB buffer was done transcardially with the help of 
a pump apparatus PA-SF (IKA Labortechnik) according to previously 
published protocols (Gage et al., 2012). Briefly, the mouse was deeply 
anesthetized by injecting of avertin-99% 2,2,2-tribromoethanol (Alta Aesar) 
dissolved in 2-methylbuthanol (Sigma) (0.2 ml per mouse of approximately 
20 g) intraperitoneally. Upon verifying the surgical plane of anesthesia by 
the lack of toe pinch-response, a lateral incision through the abdominal wall 
was made and the diaphragm was separated from the liver until the full 
exposure of the pleural cavity has been achieved by cutting through the rib 
cage. Then, a 25-gauge winged cannula was inserted to the posterior edge 
of the left ventricle of the heart, and a small incision was made to right 
atrium to discharge blood. Mice were perfused with PBS with the pump 
speed of 12, which is equal to 8 ml/min for 1 minute, and then with 4% 
PFA/PB for 3 minutes. The brain was then removed from the skull, and 
incubated with 4% PFA/PB buffer at 4°C for 16-20 hours with mild agitation. 
The brain was transferred to PBS with 0.01% sodium azide (Sigma-Aldrich) 
and kept at 4°C with moderate shaking  overnight. Chemically fixed brains 





2.6.3. Immunohistochemistry  
50 to 100 µm-thick brain sections were prepared by Vibratome (Leica 
VT1000S) or Cryostat (Leica CM3050S), washed with PBS three times at 
room temperature, and incubated for 5 minutes with moderate shaking with 
1 mg/ml sodium borohydride (Sigma-Aldrich) solution in PBS. Subsequently, 
the sections were washed with PBS and incubated with the blocking solution 
for 1 hour at room temperature, followed by an incubation with the primary 
antibody for 16-20 hours at 4°C. The sections were then washed in PBS 3 
times for 30 minutes, and incubated with secondary antibodies coupled to a 
fluorophore of choice with DAPI. Sections were washed with PBS 3 times 
for 30 minutes, and mounted with cover glass (Menzel-Gläser) and 
mounting medium (Immu-Mount).  
Blocking solution: 7.5% goat serum, 0.5% (v/v) Triton X-100, PBS 
 
2.7. Behavioral analysis  
Behavioral analysis of N4-2 conditional knockout mice (cKO) was performed 
by Prof. Dr. Hannelore Ehrenreich, Sahab Arinrad and Anja Ronnenberg 
(Clinical Neuroscience, MPIem, Göttingen) based on previously published 
papers (Dere et al., 2014, Tantra et al., 2014, Winkler et al., 2018, Dere et 
al., 2018).  
 
2.7.1. Animals and housing conditions  
For behavioral testing, mice were kept in groups of 3-5 in standard cages, 
with food, and water available ad libitum with the temperature of 20-22°C. 
Mice were housed under a 12 hour light-dark cycle with lights on at 7 AM, 
and all behavioral experiments were performed by a blind observer during 




Cre+/- (N=13), and their control Nedd4-2f/f littermates (N=16) were tested in 
an extensive behavioral test battery after the mice turned 2 months old. The 
tests were assessed in the following order: elevated plus-maze, open field, 
hole board, rotarod, bar test, pre-pulse inhibition (PPI), hearing, grip 
strength, vision, Morris water-maze (MWM), and MWM reversal test. The 
order of the tests was arranged according to the invasiveness of the test 
with a minimum of 1 day interval. After all of the tests were completed, the 
mice were sacrificed at the age of 5 months and the cortex and the 




2.7.2. Elevated plus-maze 
Each mouse was put on a central platform facing an open arm of the plus-
maze (gray Perspex with a 5 cm X 5 cm central platform, two open and two 
walled arms with the size of 30 cm X 5 cm X 15 cm and illumination density 
of 135 1x). Behavior of each mouse was recorded for 5 minutes by an 
overhead video camera assisted with a computer having automated 
tracking-software system (Viewer2, Biobserve, Germany) in order to 
calculate the time, number of visits, path length as well as velocity.  
 
2.7.3. Open field 
Exploratory capacity of the mice in a new environment was investigated 
using a gray Perspex arena having 120 cm in diameter, surrounded by a 
wall of 25 cm height. Each mouse was put into the center of the open field 
and let the mouse explore the field for 7 minutes. The exploratory ability of 
the mouse was recorded via the tracking-software; time, path length, and 
velocity in the central, intermediate, and peripheral zones of the open field 





2.7.4. Hole board 
A water deprived mouse was placed into the center of the hole board 
(transparent Perspex chamber with the dimensions of 50 cm X 50 cm X 36 
cm), having an additional non-transparent floor 3 cm above the bottom of 
the chamber with 16 holes of 2.2 cm diameter containing water, and was 
allowed to explore the chamber for 5 minutes. The number of explored holes 
by counting head dips was counted by two layers of infrared photo beams 
attached to a computer assisted with the AKS software (TSE Systems, Bad 




The rotarod (Ugo Basile Srl, Comerio, Italy), which has a horizontal rotating 
drum was set from 4 to 40 rpm with a total of 5 minutes. Mice were put on 
the drum, and soon after they were balanced, the drum was accelerated. 
The time that mice fell from the drum was measured for two consecutive 
days.  
 
2.7.6. Bar test 
Each mouse was carefully carried by the tail to steel horizontal bar with a 12 
cm length, 2.5 mm diameter and allowed to grasp the bar with both 
forepaws. Then, the mouse was moved down to make contact with the floor 
via hind paws before its tail was released. Catatonic signs were counted 
manually by measuring time of the mouse stood without moving with the 
minimum of 1 forepaw on the bar and both hind paws on the ground 





2.7.7. Pre-pulse inhibition (PPI) 
Mice were put in small metal cages (82 mm X 40 mm X 40 mm) in order to 
minimize major movements and exploratory activity, and they were 
equipped with a sensor measuring vertical movements of the floor. The 
cages were put in four sound attenuating cabinets (TSE Systems, Bad 
Homburg, Germany). Startle reflexes were evoked by applying acoustic 
stimuli via a loudspeaker. For PPI, in brief, the startle pulse was assessed 
with or without a pre-pulse stimulus of 70, 75, or 80 dB intensities. For each 
mouse, the amplitudes were averaged from two trials and PPI was 
calculated as the percentage of the startle response using the following 
formula: % PPI = 100−[(startle amplitude after pre-pulse) / (startle amplitude 
after pulse only) X 100].  
 
2.7.8. Hearing 
In this test, the startle reaction to an acoustic stimulus (pulse) on a force-
sensitive platform was measured over a period of 100 ms, beginning with 
the onset of the pulse. A habilitation session with a 65 dB background white 
noise was followed by stimuli of different intensity varying between 65 and 
120 dB. The amplitude of the startle response was set as the difference 
between the maximum force detected and the force measured before 
stimulus onset. For each individual mouse, the amplitudes of the startle 
responses were averaged according to each stimulus intensity.  
 
2.7.9. Grip strength 
A grip strength meter (TSE Systems, Bad Homburg, Germany) was used for 
measuring the forelimb grip strength. Individual mouse was lifted by the tail 
and allowed its forepaws to grasp a wire grid followed by a gentle backward 




from the forelimbs was measured. Average of three trials per each mouse 
was taken for statistical analysis (Netrakani et al., 2015). 
 
2.7.10. Vision 
Visual integrity of the mice was analyzed in an apparatus consisting of a 
Perspex box with the dimensions of 70 cm X 35 cm X 30 cm with  a 
transparent floor. The box was put on the edge of a bench with the position 
of half on the bench (ground side), half above the floor (air side). Each 
mouse was placed in the center of the base and its behavior was recorded 
for 5 minutes by measuring the percentage of time spent on the ground 
versus air side of the box as well as path length and velocity.  
 
 
2.7.11. Morris Water Maze and reversal 
A circular tank with a diameter 1.2 m and depth 0.4 m, containing opaque 
water (25 ± 1°C, depth 0.3 m) was assisted with an escape platform (10 cm 
X 10 cm) standing 1 cm below the water level. First, the mice were tested to 
swim towards the visible platform marked using a flag, and latency was 
measured with a video-tracking system for 2 days  (non-spatial training). 
The extra-maze cues were hidden during this trial. Then, it was followed by 
the hidden platform test for 8 days in which the position of the platform was 
changed and fixed throughout the test. Each mouse was trained to find a 
hidden platform that was merged 0.5 cm below water level. Every time, the 
mouse was put in the center of one of the four quadrants of the pool facing 
the pool wall, and needed to relocate the hidden platform with the help of 
extra-maze cues on the walls of the room (spatial training). Each mouse had 
four trials with an interval of 5 minutes, and allowed to look for the platform 
for 90 seconds. If the mouse failed to find the platform, it was taken to the 





The spatial probe trial started one day after the hidden platform training, in 
which the platform was removed from the pool and mice were let swim for 
90 seconds in order to check if the mice had developed a spatial bias for the 
previous platform quadrant or not. Time spent in platform zone, as well as 
latency, number of visits, and path length of each mouse was measured. 
Lastly, reversal learning was tested to see cognitive flexibility. The 
experimental procedure was the same as hidden platform training, but the 
escape platform was relocated from the original position to a new quadrant. 
Reversal learning lasted for 3 days followed by a probe trial. Time spent in 
platform zone, as well as latency, number of visits, and path length of each 
mouse was measured. 
 
2.8. Electrophysiology 
3-4 week old mice were anesthetized with Isofluorane and decapitated by 
cervical dislocation. The whole brain was removed from the skull and the 
hippocampus was isolated and immediately sliced with the thickness of 300 
µm using a tissue chopper (McILWAIN). Slices were transferred to a 
chamber filled with carbogen (95% oxygen and 5% carbon dioxide)-supplied 
artificial cerebrospinal fluid (ACSF) at 32oC for recovery. After recovery, 
slices were kept at room temperature with continuous carbogen. For the 
measurement of input-output curve (I/O), paired-pulse ratio (PPR) and early 
phase-long term potentiation (E-LTP) and late phase-long term potentiation 
(L-LTP), each slice was put on a recording chamber kept at 32oC supplied 
with carbogenated ACSF. The recording electrode (2-3 MΩ) was then filled 
with ACSF. In order to evoke fEPSPs, electric stimulations were applied to 
the Stratum radiatum at CA3/CA1 junction activating Schaffer collaterals by 
using concentric metal bipolar electrode with duration of 100 µs (1 X 100 Hz 
for E-LTP, 3 X 100 Hz for L-LTP), and recorded from the Stratum radiatum 
of the CA1 area by recording pipette. The recordings were done with the 
help of Multiclamp 700B amplifier and a Digidata 1440A. Data analysys was 




ACSF: 120 mM NaCl, 26 mM NaHCO3, 1 mM KH2PO4, 2 mM KCl, 1 mM 
MgCl2 x 6 H2O, 10 mM Glucose, 2 mM CaCl2 
 
2.8. Live imaging of primary cultured neurons 
Primary cultured cortical neurons from N4-2f/f mice were prepared and 
infected with lentivirus to express EGFP alone or EGFP together with Cre 
recombinase. At the stage of DIV16, Celltox green dye (Promega, 
Cat#G8741, 1000X) was applied in order to identify nuclei of dead cells. 
Subsequently, NMDA was applied to the culture medium at the 
concentration of 100 µM for 25 min. NMDA was washed out and live 
imaging experiments were started using Incucyte Live imaging system 
(Sartorius) with 10X objective lens for 25 hours. A snap shot of neurons was 
taken every hour. 
 
2.9. Statistical analysis  
All statistics were performed using Prism Graph Pad software. For the 
comparison of two groups, Student t-test was applied after confirming the 
normal distribution. For the comparison of multiple groups, analysis of 
variance (ANOVA) test with Tukey posthoc test. All results are presented as 











3.1. Role of Nedd4s in the postsynaptic density 
3.1.1. Localization of Nedd4-2 in the neuron 
In order to study the subcellular localization of Nedd4-2 in the neuron, we 
prepared primary cultured hippocampal neurons from Nedd4-1 (N4-1) and 
Nedd4-2 (N4-2) brain specific conditional KO mouse (Nedd4-1f/f;Nedd4-
2f/f;Emx1-Cre, N4-1/2 bDKO) and control (Nedd4-1f/f;Nedd4-2f/f, N4-1/2 
CTL), mice. Neurons were fixed at 19 days in vitro (DIV19) with 4% PFA 
and 4% sucrose for immunocytochemistry. Fixed neurons were stained with 
the anti-N4-2 antibodies together with the anti-PSD-95 antibody as a 
postsynaptic marker, and imaged with confocal microscopy (Figure 3.1). In 
N4-1/2 CTL neurons, punctate signals were detected from the anti-N4-2 
antibody partially colocalizing with signals from the anti-PSD-95 antibody. In 
N4-1/2 bDKO neurons, the number of punctate signals from the anti-N4-2 
antibody was reduced. This result indicates that endogenous N4-2 partially 
enriches at the synapse.  
 
Figure 3.1. Localization of N4-2 in primary cultured neurons. 
Immunofluorescence signals from anti-N4-2 and anti-PSD-95 antibodies in 
DIV19 hippocampal neurons prepared from N4-1/2 CTL (Nedd4-1f/f;Nedd4-
2f/f, N4-1/2 CTL) (left three panels) and N4-1/2 bDKO (Nedd4-1f/f;Nedd4-
2f/f;Emx1-Cre) (right three panels) mice. Note that N4-2 shows colocalization 




3.1.2. Identification of proline-rich protein 7 (Prr7) in proteome screen 
of Nedd4-1;Nedd4-2 substrates  
Given that K63-linked polyubiquitin chain (K63-polyUbi) plays crucial roles in 
endocytosis and lysosomal degradation (Erpapazoglou et al., 2014, Piper et 
al., 2014), and that Nedd4 family E3 ligases conjugate K63-linked 
polyubiquitin chains to substrates (Maspero et al., 2013), we hypothesized 
that physiological substrates of N4-1 and N4-2 are upregulated on the 
synaptic plasma membrane from N4-1/2 bDKO compared to the CTL. 
Biochemically purified synaptic plasma membrane (SM) fractions from N4-
1/2 bDKO and N4-1/2 CTL mice cortices (Mizoguchi et al., 1989) were 
subjected for comparative mass spectrometry by isobaric tags for relative 
and absolute quantitation (iTRAQ) in order to identify proteins upregulated in 
N4-1/2 bDKO samples as potential substrates (Ross et al., 2004; Schmidt et 
al., 2013). Among five proteins upregulated in N4-1/2 bDKO samples, Prr7 
was the only neuron specific protein while others are only expressed in 
astrocytes (i.e. gap junction protein alpha 1 (Gja1) and ATP-sensitive inward 
rectifier potassium channel 10 (Kcnj10) or ubiquitously (i.e. NADH 
dehydrogenase iron-sulfur protein 6 (Ndufs6 and CDGSH iron-sulfur 
domain-containing protein 1 (Cisd1) (Table 3.1) [Dr. Bekir Altas, Dr. Olaf 
Jahn, Dr. Samir Karaca, Dr. Henning Urlaub (Altas, 2016, PhD thesis)]. 
 







3.1.3. Neuronal N4-2 as a relevant E3 ligase gene for the regulation of 
Prr7 protein level 
Prr7 is a single pass transmembrane protein with a short N-terminal 
extracellular region and a relatively long C-terminal cytoplasmic region. Prr7 
has three potential WW domain-binding PY motifs in the middle of its 
cytoplasmic region and a PDZ-domain binding motif at its C-terminus, 
through which Prr7 forms a protein complex with PSD-95 and NMDA 
receptors (Murata et al., 2005). The result of the proteome screen was 
verified by quantitative Western blotting with the anti-Prr7 antibody in N4-1/2 
CTL and N4-1/2 bDKO cortical lysates (Appendix, Figure 5.1 A (Altas, 2016, 
PhD thesis). Prr7 level was increased 2-fold in N4-1/2 bDKO compared to 
N4-1/2 CTL. In order to determine if this increase in Prr7 protein expression 
is because of altered mRNA expression, we performed qRT-PCR (Anindya 
et al., 2007; Nakamura et al., 2011; Rossi et al., 2005). We did not detect 
any significant increase in Prr7 mRNA level in N4-1/2 bDKO, indicating that 
Prr7 protein level is regulated by of N4-1 and N4-2 E3 ligases post-
transcriptionally (Figure 3.2 A).  
We also demonstrated that neuron-specific N4-1 and N4-2 double 
conditional KO (N4-1f/f;N4-2f/f;NEX-Cre+/-, N4-1/2 nDKO) (Goebbels et al., 
2006) showed an increase in Prr7 protein at the level similar to N4-1/2 
bDKO (Figure 5.1 B), we concluded that neuronal N4-1 and/or N4-2 are 
responsible for the downregulation of Prr7.  
Next, we studied the protein levels of Prr7 in N4-1 single brain-specific 
conditional KO (N4-1f/f;N4-2+/+;Emx1-Cre+/-, N4-1 bKO) and in N4-2 single 
brain-specific conditional KO (N4-1+/+;N4-2f/f;Emx1-Cre+/-, N4-2 bKO). As 
shown in Figure 5.1 C and D, Prr7 was increased in N4-2 bKO significantly, 
while the loss of N4-1 itself has no impact on Prr7 level. We also measured 
Prr7 protein level in hippocampal lysates from 4 week-old mice (Figure 3.2 
B), and detected a significant increase in N4-2 nKO (named N4-2 KO 
hereafter). Taken all together, we conclude that N4-2 is a critical gene to 







Figure 3.2. mRNA and protein levels of Prr7. (A) Unchanged mRNA level 
in N4-1/2 bDKO. (N4-2 CTL, 1.000 ± 0.65 N=6; N4-2 KO, 0.759 ± 0.29, N=6; 
p= 0.43). (B) Significant increase of Prr7 expression in 4 week-old 
hippocampal lysate (N4-2 CTL, 1.000 ± 0.048 N=3; N4-2 nKO (named N4-2 





3.1.4. Increased surface expression of Prr7 in N4-2 KO hippocampal 
neurons 
Nedd4 family E3 ligases are crucial for ubiquitination of cell surface 
receptors, leading them to the endo-lysosomal degradation pathway (Galan 
et al., 1996; Staub et al., 1997; Persaud et al., 2011). To study if surface 
protein level of Prr7 is altered in N4-2 KO neurons, we prepared cultured 
N4-2f/f neurons, and infected lentiviruses to express EGFP or EGFP-Cre at 
DIV1. At DIV15, cell surface proteins were labeled by Sulfo-NHS-SS-biotin, 
extracted in a denaturing condition, and purified with streptavidin beads. 
Purified biotinylated proteins were subjected for Western blotting using the 
anti-Prr7 antibody. As an internal control, we studied the level of cell surface 
Transferrin, which is endocytosed in an ubiquitination-independent manner 
(Turvy & Blum, 2001). Consistent with the result using the brain tissue 
(Figure 3.2), the homogenate of N4-2 KO primary neurons showed ~2.5-fold 
increase in the total level Prr7 protein (Figure 3.3 A). Cell surface level of 
Prr7 showed more robust upregulation in the absence of N4-2 (Figure 3.3 
B), indicating that the dysregulation of Prr7 at the plasma membrane is 
probably the primary cause of the increase in N4-2 KO homogenate. 





Figure 3.3. Upregulation of total and cell surface Prr7 levels in N4-2 KO 
neurons. (A) Prr7 levels were significantly increased in N4-2 KO neuron 
lysates (N4-2 CTL, 1.000 ± 0.223, N=5; N4-2 KO, 2.707± 0.157, N=5; p= 
0.0002), (B) and biotinylated proteins (N4-2 CTL, 1.000 ± 0.265, N=4; N4-2 
KO, 4.400± 0.911, N=4; p= 0.0114). 
 
 
3.1.5. E3 ligase activity-dependent regulation of Prr7 by N4-2  
Next, we tested if expression of recombinant N4-2 (rec.N4-2) protein 
occludes the N4-2 KO phenotype (Figure 3.4). Primary cortical neuron 
cultures were prepared from N4-1f/f;N4-2f/f mice and infected with 
lentiviruses to express recombinant proteins.  Upon expression of Cre 
recombinase (Cre+, the fourth lane in Figure 3.4), Prr7 increased 3 folds 
compared to the control (Cre-, the first lane in Figure 3.4). This change was 
reverted by overexpressing rec.N4-2 (rec.N4-2 WT, the fifth lane in Figure 
3.4) but not inactive mutant of rec.N4-2 (rec.N4-2 C/S, the sixth lane in 
Figure 3.4). Interestingly, overexpression of rec.N4-2 C/S significantly 
increased Prr7 in the absence of Cre (the third lane in Figure 3.4). It is 
probably due to the dominant negative effect of this protein since rec.N4-2 
overexpression did not increase Prr7 (the second lane in Figure 3.4). We 







Figure 3.4. Rescue of Prr7 levels by re-expressing recombinant N4-2 in 
N4-1/2 KO neurons. N4-1f/f;N4-2f/f primary cortical neurons were infected 
with lentivirus expressing EGFP (Cre -) or EGFP and Cre (Cre +), with or 
without recombinant wild type N4-2 (rec.N4-2 WT) or catalytically inactive 
point mutant of N4-2 (rec.N4-2 C/S). Neurons were harvested at DIV17 and 
the level of Prr7 was analyzed by Western blotting. Signals from the anti-
Prr7 antibody were normalized to the signal from Memcode for the 
quantification. Bottom bar diagrams; quantification of relative Prr7 levels 
(N4-2 CTL 1.000 ± 0.127, N=3; N4-2 bKO, 1.94 ± 0.072, N=3; p= 0.0030. 
Represented as mean ± SEM. ***,p<0.001; **, 0.001<p<0.01; *, 






3.1.6. Ubiquitination of Prr7 by N4-2 
We studied if N4-1 and/or N4-2 ubiquitinate Prr7 in an in vitro system using 
purified recombinant proteins. For this purpose, Myc-tagged cytoplasmic 
region of Prr7 (Myc-Prr7 Cyt) was overexpressed in HEK293FT cells and 
purified using anti-Myc antibody coupled beads. Myc-Prr7 Cyt was 
incubated with ATP, recombinant ubiquitin, and E1 enzyme in the presence 
or absence of E2, N4-1, and N4-2. Subsequently, samples were subjected 
to Western blotting using an anti-Myc antibody. As shown in Figure 5.2 A, a 
smear pattern was detected in the presence of the E2 enzyme and N4-2, 
demonstrating that Prr7 is polyubiquitinated by N4-2. 
Next, we investigated if N4-1 and N4-2 ubiquitinate full-length Prr7 in the 
cellular environment by a cell-based ubiquitination assay. FLAG-tagged full-
length Prr7 (Prr7-FLAG) was overexpressed in HEK293FT cells with or 
without the EGFP-tagged N4-1 (EGFP-N4-1) and N4-2 (EGFP-N4-2). 
Proteins were extracted from cells in denaturing conditions with sodium 
dodecyl sulfate (SDS) to avoid detection of ubiquitination of Prr7-FLAG-
binding proteins. After denaturation, SDS was diluted to be below critical 
micelle concentration with TritonX-100 containing buffer. Prr7-FLAG was 
immunoprecipitated and subjected to Western blotting using anti-FLAG and 
anti-Ub antibodies (Figure 5.2 B). EGFP-N4-1- and EGFP-N4-2-dependent 
ubiquitination of Prr7-FLAG was already detectable with the anti-Ub 
antibody (Figure 5.2 B, the bottom panel). The ubiquitin signal from Prr7-
FLAG was more pronounced in EGFP-N4-2-overexpressing cells than in 
EGFP-N4-1-overexpressing cells despite that the expression of EGFP-N4-1 
was higher than that of EGFP-N4-2 (Figure 5.2 B top panel). This result 
indicates that N4-2 has more prominent activity in ubiquitination of Prr7 than 
N4-1. The same samples were blotted with antibodies to K48-linked polyUb 
and K63-linked polyUb (Figure 5.2 fourth and fifth panels). Together with 
Prr7-FLAG samples, K48-linked and K63-linked tetra-Ub were loaded in 
order to compare the titer of two anti-polyUb antibodies. Band intensities 
from tetra-Ub are comparable in two blots (arrow and arrowhead in Figure 




in the absence of overexpressed EGFP-tagged Nedd4 proteins, strong 
signals were detected by the anti-K48-linked polyUb antibody (the third lane 
in the top panel of Figure 5.2 B fourth panel). It is probably for the clearance 
of an excess of Prr7-FLAG by endoplasmic reticulum-associated protein 
degradation, where K48-linked polyUb plays crucial roles (Lemus and 
Goder, 2014; Zemoura et al., 2013) Western blotting using the anti-K63 
polyUb antibody shows similar results to the anti-Ub antibody (compare third 
and fifth panel in Figure 5.2 B). Interestingly, overexpression of recombinant 
EGFP-N4-1 or -N4-2 diminished the signal from the anti-K48-linked polyUb 
(the first and second lanes in Figure 5.2 B fourth panel). We interpret this as 




3.1.7. First and second WW domain-binding PY motifs of Prr7 as 
responsible regions for N4-2-binding and for N4-2-dependent 
ubiquitination 
Each of the Nedd4 family E3 ligases recognizes its own substrates via direct 
bindings between WW domains of E3s and PY motifs of substrates (Staub 
et al., 1996; Kanelis et al., 2001; Chong et al., 2010). In order to study which 
PY motifs in Prr7 mediate interaction with N4-2, we generated expression 
vectors for missense mutants of Prr7 at the first and/or second PY motifs 
(PY1, PY2, and PY1/2 mutants; Figure 3.5 A). Pull-down experiments using 
GST-N4-2 and HA-tagged Prr7 (HA-Prr7) show that PY1 and PY2 mutants 
as well as wild type (WT) Prr7 bind to GST-N4-2 while the PY1/2 mutant 
abolishes N4-2’s binding activity (Figure 3.5 B). This result indicates that 
one of PY1 or PY2 is sufficient for binding to N4-2 and that the loss of one is 
compensated by the other. Next, we studied if N4-2-Prr7 binding is required 
for N4-2-dependent ubiquitination of Prr7 in a cell-based ubiquitination 
assay. As shown in Figure 3.5 C, Immunoprecipitated HA-Prr7 from 
HEK293FT cells expressing recombinant N4-2 showed a robust signal from 
the anti-K63 polyUb antibody. HA-tagged PY1/2 mutant of Prr7, on the other 




controls, showing that the binding between WW domains of N4-2 and PY 
motifs of Prr7 is required for conjugation of K63 polyUb chains to Prr7.  
 
Figure 3.5. PY motif dependent binding and ubiquitination of Prr7. (A) 
The domain structure of Prr7. Two WW domain-binding PY motifs (PY1 and 
-2) are in the middle of its cytoplasmic region. The HA tag was inserted in 
front of the PDZ-binding motif for the biochemical experiments in (B) and 
(C). (B) Wild type (WT), PY1 single, PY2 single, or PY1 and PY2 double 
mutants (PY1/2) of HA-tagged Prr7 were expressed in HEK293FT cells (top 
panel). Cell extracts were subjected to affinity pull-down assay using GST-
tagged full length N4-2. Note the lack of binding of PY1/2 mutant (last lane 
in the second panel). The amount of GST-N4-2 (arrowhead) used for the 
assay is comparable to that of the negative control GST (arrow) at the 
bottom panel. (C) Cell-based ubiquitination assay using untagged N4-2, and 
wild type (WT) or PY1/2 mutant of HA-tagged Prr7. Despite of the high level 
of N4-2 in the cell lysate in the PY1/2 expressing cells (the second lane in 
the top panel), the signal from the anti-K63-polyUb antibody was clearly 
weaker (the second lane in the bottom panel) than the one from the WT HA-




3.1.8. Subcellular localization of Prr7  
In primary cultured hippocampal neurons, Prr7 is localized at the synapse 
(Kravchick, et al., 2016). However, its synaptic distribution has never been 
addressed in the brain tissue or at the super resolution level. Given that anti-
Prr7 antibodies for immunohistochemistry are not available, EGFP-tagged 
Prr7 (Prr7-EGFP) was expressed in the hippocampal CA1 neurons to study 
its localization. We transfected neurons at E14.5 with expression vectors for 
myrVenus and Prr7-EGFP by in utero electroporation (IUE) method. Brains 
were fixed with 4% PFA at P22, 70 mm slices were prepared, and Venus 
and EGFP signals were imaged at the CA1 region of hippocampus by 
stimulated emission depletion (STED) microscopy. As shown in Figure 3.6, 
Prr7-EGFP was enriched at the tip of dendritic spines. 
 
 
Figure 3.6. Localization of Prr7-EGFP in CA1 hippocampal neurons. 
Neurons were transfected with expression vectors for myrVenus and Prr7-
EGFP by IUE. The brain was fixed at P22 and signals from myrVenus and 





3.1.9. N4-2 regulates spine size and leads to emergence of bifurcated 
spines  
Previously, we have demonstrated the relative abundance of N4-2 mRNA in 
central murine nervous system by in situ hybridization and observed relative 
enrichment of N4-2 in hippocampus (Ambrozkiewicz, 2015, PhD thesis, 
Figure 5.3 A). Then, we studied the role of N4-2 in spinogenesis and 
dendritic spine morphology in the hippocampus by using in utero 
electroporation and targeted hippocampal progenitors at E14.5 in control 
(Nedd4-2f/f) and neuron-specific N4-2 conditional knockout mice (Nedd4-
2f/f;NEX-Cre+/-, Nedd4-2 KO) by using GFP- and myr-Venus expression 
plasmids, and studied the total number and morphology of dendritic spines 
specifically on primary branches of apical dendrites of hippocampal CA1 
pyramidal neurons using STED microscopy (Figure 5.3 B). Despite the fact 
that there was no change in dendritic spine density (Fig 5.3 C), the 
morphological study of spines in N4-2 KO neurons showed an interesting 
phenotype. We saw an elevation in the length of filopodia, thin, and 
mushroom spines (Figure 5.3 D), and also an increase in the thin spine 
head size (Figure 5.3 E). In addition to that, we observed a decrease in the 
number of mushroom spines and increase in bifurcated spines (Figure 5.3 
F) upon loss of N4-2. We concluded that the deletion of N4-2 in neurons 
causes some abnormalities in spine morphology, and N4-2 regulates 
dendritic spine development (Ambrozkiewicz, 2015, PhD thesis).  
Since Prr7 is the only neuronal substrate of N4-2 found in our proteomic 
screen and we believe that the spine phenotype is due to the increased 
expression of Prr7, we decided to cross our N4-2 KO mouse line with Prr7 
KO mouse line (Prr7f/f;CamKIIα-Cre) for further experiments. Importantly, 
regarding the possible dendritic spine experiment, Drebrin1 has a role in 
spine formation and stabilization (Hayashi et al., 1996; Hering & Sheng, 
2001), and the Dbn1 gene is located approximately 300 bp downstream of 
the last exon of Prr7 on chromosome 5. Therefore, we wanted to study the 




Western blotting to eliminate the possibility of a dendritic spine affect due to 
altered Drebrin1 levels. As seen in Figure 3.7, there was no significant 
change in Drebin1 protein expression in the cortical lysates of 3 week old 
mice, whereas Drebrin1 level was significantly decreased in 3 month old 
Prr7 KO mice, stating that spine structure could be altered in older mice. 
 
Figure 3.7. Drebrin1 protein level in 3 week-old and 3 month-old mice. 
(A) Unaltered Drebrin1 levels in 3 week-old Prr7 KO mice (Prr7 CTL, 1.000 
± 0.082 N=5; Prr7 KO, 1.107 ± 0.221, N=5; p= 0.663). (B) Drebrin1 level 
was significantly decreased in 3 month old Prr7 KO mice (Prr7 CTL, 1.000 ± 





3.1.10. Improved memory formation and re-learning ability in N4-2 KO 
mice  
Given that N4-2 and Prr7 localize at the postsynapse and that dynamic 
structural change of the postsynapse in the hippocampal CA1 region is 
essential for special memory formation, we studied behavioral changes 
upon neuronal loss of N4-2 in collaboration with Prof. Dr. Hannelore 
Ehrenreich, Sahab Arinrad and Anja Ronnenberg (MPI-EM, Göttingen). N4-
2 CTL and N4-2 KO were subjected to a full battery of behavioral tests, 
including elevated plus maze (EPM), open field (OF), holeboard exploration, 
prepulse inhibition, rotarod, grip strength, bar test, Morris water maze 
(MWM) and MWM reversal tests (Table 3.2) (Figures 3.8-3.13).  
N4-2 KO mice showed no change in the elevated plus-maze in terms of 
time, visits, path length and velocity (Figure 3.8), as well as time spent in the 
open field (Figures 3.9) compared to CTL animals. However, N4-2 KO mice 
showed increased velocity and path length in the open field test, indicating 
mild hyperactivity (Figures 3.9 A and B). However, we did not see the same 
outcome in holeboard exploration test (Figure 3.9 F). N4-2 KO mice had 
impaired motor learning in motor performance tests, Rotarod, and grip 
strength test (Figures 3.10 A and 3.11 A), while sensory performance such 
as hearing (Figure 3.10 F) and vision (Figure 3.11 B-F) were intact. There 
was no difference in terms of catatonic signs in the bar test (Figure 3.10 C). 
Although there was an impairment in muscle strength and motor 
coordination in N4-2 KO, we observed increased spatial memory (Figure 
3.12 B) and re-learning ability in N4-2 KO mice (Figure 3.13 A). In the 
MWM, N4-2 KO mice were found to have normal motor activity and 
motivation to reach to the visible platform by showing no significant change 
in time spent in platform zone, (Figure 3.12 C) path length (Figure 3.12 D), 
and in number of visits (Figure 3.12 E) and latency to first visit (Figure 3.12 
F), yet Figure 3.12 B demonstrated that N4-2 KO mice performed better 
shown by significantly less latency. In reversal, those mice showed no 
significant change in time spent in platform zone (Figure 3.13 B), but 




visits (Figure 3.13 D) and latency to first visit (Figure 3.13 E), concluding 
that N4-2 KO showed an improved memory formation.  
 
Table 3.2. Behavioral tests performed using N4-2 mice 
Behavioral domain Test paradigm Age ♂ 
Anxiety Elevated plus maze 2 months Open field 
Locomotion & 
exploration 
Open field 2 months Holeboard exploration 
Sensory performance 
	 	Hearing Prepulse inhibition 3 months 
Vision MWM visible platform 3 months 
Motor performance 
	 	Motor learning Rotarod 2-3 months 
Muscle strength Grip strength 2-3 months 
Health status Body weight 3 months 
Cortical network 
function 
	 	Sensorimotor gating Prepulse inhibition 
	Catatonic signs Bar test 2-3 months 
Cognition 
	 	Spatial memory MWM 5 months 





	Figure 3.8. (Figure is on the following page) General behavioral 
examination in N4-2 mice in elevated plus maze test. No anxiety 
phenotype was observed in N4-2 KO mice in Elevated Plus Maze (EPM) 
time in open arms (A), EPM time in walled arms (B), EPM time in center (C), 
EPM number of visits open arms (D), EPM visits walled arms (E), EPM visits 
center (F), EPM path length (G), EPM velocity (H), EPM % time open arms 
(I), EPM % of visits open arms (J). (N4-2 CTL N=16, N4-2 KO mice N=13) 












































































































































 Figure 3.9. General behavioral examination in N4-2 mice in open field 
test.  Significant increase was observed in Open Field (OF) path length (A) 
(p=0.0216), and OF velocity (B) (p=0.0217), in N4-2 KO mice. No changes 
observed in OF time in periphery zone (C), OF time in intermediate zone 
(D), OF time in center zone (E), number of visits in Holeboard Exploration 
(F), in control and N4-2 KO mice (N4-2 CTL N=16, N4-2 KO mice N=13) 
Represented as mean ± SEM. 




























































































Figure 3.10. General behavioral examination in N4-2 mice in rotarod 
and prepulse inhibition tests. Increased latency in Rotarod (A), slightly 
increased body weight during the Rotarod test (B) (p=0.0487), no change in 
Catatonic signs (C), no change in Prepulse inhibition (D), no change in body 
weight during Prepulse inhibition (E), no significant change in Hearing (F) in 
N4-2 KO mice (N4-2 CTL N=16, N4-2 KO mice N=13) Represented as 
mean ± SEM.  
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Figure 3.11. General behavioral examination in N4-2 mice in motor and 
visual funcitons. Decreased grip strength (A) (p=0.0006), no change in 
vision path length (B) as well as vision velocity (C), vision time air (D), vision 
time ground (E), vision % time air (F) in N4-2 KO mice (N4-2 CTL N=16, N4-
2 KO mice N=13) Represented as mean ± SEM. 	
  



















































































 Figure 3.12. Improved memory formation in N4-2 mice. (A) No change 
was observed in the MWM with a visible platform. (B) Time to reach to the 
platform was less in N4-2 KO mice compared to CTL in the MWM with a 
hidden platform. No change was observed in time in the platform zone in 
MWM probe trial (C), path length in platform zone in the MWM probe trial 
(D), number of visits to platform zone in MWM probe trial (E), latency to visit 
the platform zone in the MWM probe trial (F) in N4-2 KO mice (N4-2 CTL 
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 Figure 3.13. Improved re-learning ability in N4-2 mice. N4-2-KO mice 
exhibited enhanced re-learning ability in the MWM reversal test compared to 
CTL (A). Despite no change in the amount of time spent in the platform zone 
in the MWM reversal test (B), significant changes were observed in path 
length in the platform zone (C) (p=0.038), and number of visits to the 
platform zone (D) (p=0.0325), and latency to the platform zone in the in 
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the CTL (N4-2 CTL N=16, N4-2 KO mice N=13) Represented as mean ± 
SEM.  
 
3.1.11. No change in postsynaptic density proteins in hippocampal 
tissue of N4-2 KO mice subjected to behavior analysis  
 
After the behavioral analyses, we collected the mice and isolated the 
hippocampi of some pairs of the N4-2 KO and CTL mice to study levels of 
postsynaptic density (PSD) proteins, including Prr7 (Figure 3.14 A), GluN2B, 
PSD-95, CamKIIα (Figure 3.14 B), GluN1, and GluA2/3 (Figure 3.14 C). We 





























































































































































































































Figure 3.14. Intact expression levels of postsynaptic density proteins 
PSD-95, CamKIIα, GluN1, GluN2B, GluA2/3. (A) Prr7 levels were 
significantly increased in N4-2 KO hippocampal lysates. N4-2 CTL, 1.000 ± 
0.05 N=8; N4-2 KO, 2.365 ± 0.155, N=6; p= 0.00000052. (B) No significant 
change in GluN2B levels (N4-2 CTL, 1.000 ± 0.096 N=5; N4-2 KO, 1.02 ± 
0.081, N=6; p= 0.87), as well as PSD-95 levels (N4-2 CTL, 1.000 ± 0.076 
N=8; N4-2 KO, 0.994 ± 0.082, N=5; p= 0.96), and CamKIIα (lower panel) 
(N4-2 CTL, 1.000 ± 0.036 N=8; N4-2 KO, 0.919 ± 0.036, N=5; p= 0.114). (C) 
No significant change in GluA1 levels (N4-2 CTL, 1.000 ± 0.009 N=6; N4-2 
KO, 1.02 ± 0.065, N=6; p= 0.98), as well as GluA2/3 levels (N4-2 CTL, 
1.000 ± 0.276 N=7; N4-2 KO, 1.3 ± 0.373, N=6; p= 0.51). Represented as 
mean ± SEM.  
 
We also performed biotinylation assays to analyze surface protein levels of 
AMPA and NMDA receptor subunits in N4-2 KO primary cultured 
hippocampal neurons. For this purpose, we did immunoblotting against 
GluN1, GluN2B, GluA1, and GluA2 and normalized surface protein levels to 
Transferrin using biotinylated samples. We did not see any significant 
change in any of those receptor subunits (Figures 3.15 A and B).	
	
	








Figure 3.15. No change in surface levels of glutamate receptors in N4-2 
KO hippocampal neurons. (A) No significant changes in GluN2B (N4-2 
CTL, 1.000 ± 0.046 N=3; N4-2 KO, 1.024 ± 0.079, N=3; p= 0.81) and GluA2 
(N4-2 CTL, 1.000 ± 0.178 N=3; N4-2 KO, 0.828 ± 0.055, N=3; p= 0.41) (B) 
GluN1 (N4-2 CTL, 1.000 ± 0.157 N=3; N4-2 KO, 1.086 ± 0.186, N=3; p= 
0.74) and GluA1 (N4-2 CTL, 1.000 ± 0.171 N=3; N4-2 KO, 0.934 ± 0.235, 
N=3; p= 0.83), observed in biotinylated N4-2 KO samples. Represented as 































































































































3.1.12. Electrophysiology  
 
Trommald and colleagues proposed a link between LTP and bifurcated 
spines by demonstrating that stimulated dendrites show more bifurcated 
spines compared to nonstimulated dendrites (Trommald et al., 1996). 
However, involvement of bifurcated spines in memory formation is still 
unclear. After discovering improved memory and re-learning ability in N4-2 
KO mice, we did a set of electrophysiology experiments in collaboration with 
Prof. Dr. Jeong Seop Rhee and Dr. Erinn Gideons (MPI-EM, Göttingen) 
(Figures 3.16-3.17). We measured paired pulse ratios (PPR) and input-
output (I/O) curves to analyze presynapse responses and demonstrated that 
the presynaptic structure was intact (Figures 3.16 A and B). There was no 
change between the N4-2 KO and CTL mice in either early phase LTP (E-
LTP) or long term depression (LTD) (Figures 3.17 A and B), whereas there 
was significant increase in late phase LTP (L-LTP) in N4-2 KO mice (Figure 
3.17 C). Moreover, we managed to rescue this phenotype by deleting one 
allele of Prr7 in N4-2 KO mice (N4-2f/f;Prr7f/+;NEX-Cre+/-), indicating that Prr7 
is responsible for this increase. Note that Prr7 protein levels were decreased 




Figure 3.16. Intact presynaptic structure observed in N4-2 mice. (A) 
Paired pulse ratio (PPR), (B) input-output (I/O) curve showed that there is 










Figure 3.17. LTD and LTP measurements in N4-2 mice. No significant 
change in (A) E-LTP, and (B) LTD between N4-2 KO and CTL mice. (C) 
Significant increase in L-LTP in N4-2 KO mice, rescued by N4-2 KO, Prr7 
heterozygous mice (N4-2f/f;Prr7f/+;NEX-Cre+/-). (D) Decreased Prr7 protein 







































































































































3.1.13. Intact levels of p-CaMKIIα and CaMKIIα in stimulated 
hippocampal tissue of N4-2 KO mice 
 
Next, we studied the levels of phospho-CamKIIα and in the CA1 region of 
the hippocampus upon stimulation of Shaffer collaterals of N4-2 KO. For this 
purpose, we sliced the hippocampi of 3-4 week old mice with the thickness 
of 300 µm, and incubated the slices with carbogen (95% oxygen and 5% 
carbon dioxide)-supplied artificial cerebrospinal fluid (ACSF) at 32°C 
followed by 10 minutes baseline recording and 10 minutes recording after 
stimulation with 100Hz for 3 times to induce L-LTP. Stimulated CA1 regions 
were isolated and lysed for immunoblotting against p-CamKIIα and 
CamKIIα. We did a pilot experiment to see if these L-LTP conditions were 
able to induce changes in phoshphorylation of CamKIIα. In order to do this, 
we did immunoblotting against CamKIIα, which has been linked to 
hippocampal LTP and learning (Hell, 2014). As shown in Figure 3.18 A, p-
CamKIIα levels were increased upon L-LTP induction, indicating that 
stimulation was working. However, we were only able to detect a statistical 







Figure 3.18. Intact levels of p-CamKIIα in L-LTP-induced N4-2 KO 
hippocampal neurons. (A) Increased p-CamKIIα levels upon L-LTP 
induction. (B) No change in p-CamKIIα/CamKIIα levels in stimulated (N4-2 
CTL, 1.000 ± 0.074 N=3; N4-2 KO, 0.817 ± 0049, N=3; p= 0.062) and 
nonstimulated pairs (N4-2 CTL, 1.000 ± 0.168 N=3; N4-2 KO, 0.903 ± 0.134, 






















































































































3.2. Cell autonomous and non-cell autonomous regulations of 
excitotoxicity by N4-2 
 
3.2.1. N4-2 KO neurons are resistant to neural death upon NMDA 
treatment  
It was recently reported that Prr7 plays crucial roles in NMDA-mediated 
excitotoxicity at the PSD (Kravchick et al., 2016). We decided to measure 
excitotoxicity in N4-2 KO neurons. For this purpose, we prepared primary 
cultured cortical neurons using N4-2f/f mice, and infected with lentivirus 
expressing only dsRed (N4-2 CTL) or dsRed together with Cre recombinase 
(N4-2 KO). At DIV16, we applied a fluorescence dye (Celltox green, 
Promega) that is integrated in nuclei of dead cells, followed by NMDA 
application (100 uM for 25 min). After washout of NMDA, we did live imaging 
on treated neurons using the Incucyte Live imaging system (Figure 3.19). 
We observed that in N4-2 CTL neurons, the high dose of NMDA caused 
excitotoxicity and killed the cells, whereas N4-2 KO neurons did not show 
NMDA-dependent cell death, indicating that N4-2 KO neurons were 













Figure 3.19. Resistance of N4-2 KO neurons to excitotoxicity upon 
NMDA treatment. Primary cultured cortical N4-2 CTL (A and B) and N4-2 
KO (C and D) neurons were incubated with NMDA (100 uM for 25 min) at 
DIV16. After washing out NMDA, uptake of Celltox green was monitored by 
live imaging using Incucyte Live imaging system with 10X objective lens for 
25 hours. Representative images before (A and C) and after (B and D) the 
NMDA treatment showed that there were significantly more dead green cells 
detected in N4-2 CTL cells than N4-2 KO (compare panels B and D). 
Represented as mean ± SEM. N=5 for each condition, Two way ANOVA, 
Tukey posthoc test, interaction p<0.0001, time p<0.0001, treatment 
p=0.012, subjects p<0.0001.  
 
 
3.2.2. Astroglial protein Connexin-43 as a substrate of Nedd4-2 E3 
ligase 
 
Connexin-43 (Cnx-43) is another protein identified in the proteome screen of 
proteins upregulated in N4-1/2 bDKO. It has been reported previously that 
Cnx-43 is expressed mainly in astrocytes (Dere et al., 2012), and a binding 
assay revealed that the second WW domain of N4-1 binds to the PY motif of 


































Cnx-43 (Kawabe et al., 2010; Leykauf et al., 2006). Moreover, it has been 
shown that in N4-1 knockdown cells, Cnx-43 levels were significantly 
increased (Girao et al., 2009). It has also been reported that glial Cnx-43 is 
critical for neuroprotection after stroke (Nakase et al., 2004). 
 
Like Prr7, we also verified the proteome screen results for Cnx-43 by 
quantitative Western blotting with the anti-Cnx-43 antibody using N4-1/2 
CTL and N4-1/2 bDKO P2C fractions (Figure 5.4 A), and demonstrated that 
Cnx-43 level was altered. As shown in Figure 5.3 A, Cnx-43 level showed a 
2-fold increase in N4-1/2 bDKO compared to N4-1/2 CTL. Unaltered Cnx-43 
mRNA levels in N4-1/2 bDKO indicate that the enhancement in Cnx-43 
protein was caused posttranscriptionally (Figure 3.19). We also did 
quantitative Western blotting using neuron-specific N4-1 and N4-2 double 
conditional KO (N4-1f/f;N4-2f/f;NEX-Cre+/-, N4-1/2 nDKO) and demonstrated 
that there is no significant change in Cnx-43 levels compared to control 
(Figure 5.4 B). We concluded that astroglial N4-1 and/or N4-2 are 
responsible for the downregulation of Cnx-43.  
 
 
Figure 3.20. Cnx-43 mRNA levels in N4-1 and N4-2 conditional KO 
mouse lines. mRNA levels of Cnx-43 in from cortices of 6 weeks old N4-1/2 
CTL (N4-1f/f;N4-2f/f) and N4-1/2 bDKO (N4-1f/f;N4-2f/f;Emx1 Cre) mice (N4-
1/2 bCTL, 1.00 ± 0.0398, N=3; N4-1/2 bDKO, 0.91 ± 0.168 N=3; p= 0.741. 
































We also observed that Cnx-43 level was not increased in N4-1 single brain-
specific conditional KO (N4-1f/f;Emx1-Cre, N4-1 bKO), whereas N4-2 single 
brain-specific conditional KO (N4-2f/f;Emx1-Cre, N4-2 bKO) showed 
significant increase in Cnx-43 (Figure 5.4 C and D). Taken all together, 
endogenous glial N4-2 is the relevant E3 ligase that suppresses Cnx-43 at 
the posttranscriptional level.  
 
3.2.4. Ubiquitination of Cnx-43 by N4-2 
We next studied if N4-1 and N4-2 ubiquitinate Cnx-43 in vivo by doing a cell-
based ubiquitination assay. C-terminally HA-tagged Cnx-43 (Connexin-43-
HA or Cnx-43-HA) was overexpressed in HEK293FT cells with or without 
the EGFP-tagged N4-1 (EGFP-N4-1) and N4-2 (EGFP-N4-2), followed by 
immunoprecipitation and subjected to Western blotting using anti-HA and 
anti-Ub antibodies (Figure 5.5). EGFP-N4-1- and EGFP-N4-2-dependent 
ubiquitination of Cnx-43-HA was observed with the anti-Ub antibody (Figure 
5.5 third panel). More importantly, the level of the ubiquitin signal from was 
more pronounced upon EGFP-N4-2-overexpression than EGFP-N4-1 
although very high expression of EGFP-N4-1 was seen (Figure 5.5 top 
panel), indicating that N4-2 has more prominent activity than N4-1 in 
ubiquitination of Cnx-43. We also blotted the samples with antibodies to 
K48-linked polyUb and K63-linked polyUb (Figure 5.5 fourth and fifth 
panels), and loaded K48-linked and K63-linked tetra-Ub next to Cnx-43-HA 
samples to compare the titer of two anti-polyUb antibodies. As observed in 
the cell based ubiquitination assay done for Prr7, we detected strong signals 
from the anti-K48-linked polyUb antibody (the third lane in the fourth panel 
of Figure 5.5) in the absence of any EGFP-tagged Nedd4 proteins, probably 
because of the enhanced removal of Cnx-43-HA by endoplasmic reticulum-
associated protein degradation that involves K48-linked polyUb (Lemus and 
Goder, 2014; Zemoura et al., 2013). Western blotting using the anti-K63 
polyUb antibody revealed similar results as anti-Ub antibody in Figure 5.5 
third panel, indicating that N4-2 prominently conjugated Cnx-43 with K63-





 4.1. Characterization of Prr7 as a substrate of N4-2 
Ubiquitination is a posttranslational protein modification involved in wide 
array of cellular functions, including proteasomal protein degradation, DNA 
damage response, and endocytosis. Substrate specificity of ubiquitination is 
determined by E3 ligases, which are encoded by ~600 genes in human 
genome. The loss- or gain-of-function of E3 ligase genes lead to 
neurological disorders, including neurodegenerative disease (e.g. 
Parkinson’s and Alzheimer’s diseases), autism spectrum disorders, and 
intellectual disabilities (George et al., 2018). Identification of N4-1 and N4-2 
were done in a screening study to elucidate developmentally downregulated 
genes in the mouse brain (Kumar et al., 1992). N4-1, which was the first 
identified and most investigated member of the Nedd4 family has been 
linked to several potential substrates, showing its general function in 
vesicular trafficking and sorting (Yang and Kumar, 2010). N4-2 is of 
particular importance for neuronal development and function; loss of N4-2 
causes familial heterotopia, which is a brain malformation caused by 
abnormal neuronal migration (Broix et al., 2016) and the gain-of-function 
N4-2 is a potential cause of familial epilepsy (Dibbens et al., 2007). 
The present study demonstrates (i) a novel biological mechanism where a 
postsynaptic transmembrane protein Prr7 is regulated by N4-2 (Figure 3.4), 
(ii) the neuron-specific loss of N4-2 results in improved memory formation 
(Figure 3.12), as well as L-LTP (Figures 3.16-3.17).  
 
4.2. Identification of novel substrates of N4-2 
One of the well established substrates of N4-2 is the epithelial sodium 
channel, ENaC. ENaC is composed of alpha, beta, and gamma subunits, 
among which beta and gamma subunits have PY motifs at their C-termini. 
ENaC is highly expressed on the apical plasma membrane of the distal tube 




reabsorption of sodium from the lumen into the epithelial cytoplasm. 
Eventually, ENaC increases the sodium level in the blood plasma, leading to 
the secondary reabsorption of water from the renal collecting duct. The 
regulation of ENaC is of particular importance to control of blood pressure. 
Upon activation of renin-angiotensin-aldosterone system in response to an 
acute decline of blood pressure, the steroid hormone aldosterone promotes 
the transcription of ENaC, leading to the compensatory maintenance of 
blood pressure. In the pathological condition, Liddle syndrome patients with 
the deletion or missense mutation of the cytoplasmic C-terminus of ENaC 
suffer from hypertension caused by enhanced reabsorption of sodium in the 
nephron, indicating the gain-of-function of ENaC (Harvey et al., 2001; 
Kamynina et al., 2001; Rossier & Schild, 2008). Indeed, in the mouse model 
of Liddle syndrome with a premature stop codon in beta-subunit of the 
ENaC gene, the reabsorption of sodium was increased without affecting the 
channel activity per se or the level of ENaC mRNA (Pradervand et al., 1999; 
Pradervand et al., 2003). Interestingly, mutations of C-terminus of ENaC 
disrupt a WW domain-binding PY motif. Originally, it was reported that N4-1 
binds to this PY motif and ubiquitinates ENaC in vitro (Staub et al., 1996; 
Fotia et al., 2003). However, recent evidence has shown that N4-2 has more 
prominent E3 ligase activity for ENaC (Zhou et al., 2007) and levels of 
ENaC are increased in the kidney-specific N4-2 conditional KO mouse 
(Kimura et al., 2011). The history of studies of ENaC ubiquitination implies 
that comprehensive studies are required to identify and characterize the 
bona fide relationship between an E3 ligase and its substrates.  
Besides ENaC, voltage-gated sodium channels Nav1.2, Nav1.3, Nav1.5 
(van Bemmelen et al., 2004; Rougier et al., 2005), and potassium channels 
KCNQ1, KCNQ2/3 and KCNQ3/5 (Ekberg et al., 2007; Jespersen et al., 
2007) have been reported as substrates of N4-2. However, the function of 






In our previous study, we screened for proteins upregulated in the synaptic 
plasma membrane fraction from N4-1/2 bDKO mice to identify potential 
substrates of N4-1 and N4-2. Among three identified transmembrane 
proteins, Kir4.1 and Cnx-43 were characterized as key substrates in 
astrocytes, whereby they control the neuronal network activity in a non-cell 
autonomous manner (Altas et al., 2019, manuscript in revision). In our 
present study, we characterized the third potential substrate protein, Prr7 
with biochemical, cell biological, and behavioral methods. Prr7 was originally 
cloned as a postsynaptic transmembrane protein forming a complex with 
PSD-95 and NR2B (Murata et al., 2005). Given that PSD-95 binds to Prr7 
through its PDZ domain, it is very likely that the C-terminal PDZ-binding 
motif of Prr7 is required for the interaction with PSD-95 and for the complex 
formation with NR2B. We demonstrated that the first or second PY motifs of 
Prr7 are essential for its binding to and ubiquitination by N4-2 (Figure 3.5 B). 
Despite highly homologous WW domains of N4-1 and N4-2 (i.e. 65 to 75 % 
identity, Asher et al., 2003), only N4-2 has a prominent activity as an E3 
ligase for Prr7 (Figure 5.2). Consistent with this result, Prr7 protein level was 
increased in N4-2 KO neurons while there were no changes in Prr7 protein 
expression in N4-1 KO neurons (Figure 5.1).  We found that N4-2 has a 
potential to conjugate K63-polyUb to Prr7 in the cell-based ubiquitination 
assay (Figures 5.2 B and 3.5 C). K63-polyUb plays critical roles in 
endocytosis/lysosomal degradation, DNA damage response, and activation 
of NF-kappaB signaling (Erpapazoglou et al., 2014; Mattiroli et al., 2012; 
Chen, 2005). In our biotinylation assay (Figure 3.4), the level of Prr7 was 
more prominently upregulated in the plasma membrane than in the total 
lysate. This result indicates that Prr7 is regulated by N4-2 at the cell surface 
primarily, probably via endocytosis/lysosomal degradation, rather than in the 
cell body, e.g. transcriptionally. Indeed, the level of mRNA was not changed 
in N4-1/2 bDKO (Figure 3.2 A).  
 
Developmentally, Prr7 level is upregulated in the brain from E18 till P42 
(Murata et al., 2005). Such a temporal expression pattern resembles those 
of other postsynaptic proteins, including PSD-95 and Neuroligin-1 (Song et 




synaptyogenesis of excitatory synapses. Prr7, on the other hand, impairs 
synapse formation by blocking the non-canonical Wnt pathway in a CamKII-
dependent manner (Lee et al., 2018).  
 
The level of N4-2 is downregulated developmentally in the brain from E13 
(Hsia et al., 2014). This expression profile implies that N4-2 may play roles 
in the early phase of the neuronal development, including neuronal 
migration that may affect cortical circuit formation (Broix et al., 2016). 
Inversely proportional expression profiles of N4-2 and Prr7 may be 
accounted for by N4-2 dependent ubiquitination of Prr7. After P28, around 
the time that synapse elimination is completed, the level of N4-2 stays 
constant (Takeda, 2012, PhD thesis). N4-2 is localized to the synapse in 
mature primary cultured neurons (Figure 3.1). Our finding provides a novel 
insight for proteostasis at the postsynapse.  
  
 
4.3. Neuronal N4-2 enhances spatial reversal learning 
Behavior of mice as well as humans correlates with activity of certain 
neuronal pathways. It has been reported that KOs of genes involved in 
synaptic transmission, i.e. calcineurin, CamKIIα, and NR2B show deficit in 
spatial learning in the MWM test (Zeng et al., 2001; Park et al., 2016). 
Similarly, several E3 ligase KO mice, including Ube3A KO, neuron specific 
chromodomain helicase DNA binding protein 1 (Chd1) conditional KO, and 
IDOL KO show impaired spatial learning (Jiang et al., 1998; Schoberleitner 
et al., 2019; Pick et al., 2013; Gao et al., 2017). Conversely, Cdk5 KO, 
polyadenylate-binding protein-interacting protein 2 (PAIP2A) KO, and ORL1 
KO mice show improved spatial learning and/or memory consolidation in 
MWM test (Hawasli et al., 2007; Khoutorsky et al., 2013; Plattner et al., 
2014). Interestingly, Cdk5, PAIP2A, and ORL1 promote the expression or 
activity of calcineurin or CamKIIα, respectively, via conventional intracellular 
signaling, protein phosphorylation and calcium signaling. In order to test if 
N4-2 plays a role in spatial memory formation, we applied general 
behavioral analyses together with the MWM test and the MWM reversal test 




In our study, there was no anxiety phenotype in N4-2 KO mice in the 
elevated plus-maze and open field tests. Interestingly, in the open field test, 
N4-2 KO mice showed increased values both in velocity and path length, 
suggesting that these mice could be more curious of novel environments 
and also exhibit mild hyperactivity. However, we did not see the same 
outcome in holeboard exploration test. Moreover, these mice showed 
impaired motor learning in motor performance tests, such as rotarod and 
grip strength test, while sensory performances, such as vision and hearing 
were found to be intact. The hearing curve results might indicate reduced 
hearing at higher intensities, but that results would need to be confirmed by 
acoustic evoked potentials. 
Very interestingly, despite the significant decrease in grip strength and 
motor coordination observed in N4-2 KO, we observed enhanced spatial 
memory and re-learning ability in N4-2 KO mice (Figure 3.12 and 3.13). The 
MWM test is known to be a strong and dependable test that is related to 
hippocampus-dependent learning and memory (Morris, 1984; Vorhees & 
Williams, 2010). As the N4-2 KO mice showed decreased latency to find the 
hidden platform in comparison to the CTL mice during the learning trials, the 
N4-2 KO were therefore found to have enhanced hippocampal-dependent 
learning and memory compared to control mice. Moreover, the MWM 
reversal test, which is even more complicated since it is not only changing 
the position of the platform, but also removing the platform for some time 
and then changing the position of it. Additionally, only a limited time is given 
to mice to adapt to the changed situation and re-learn the task. It was 
observed that N4-2 KO mice have significantly higher visits to the new 
platform zone and path length in the new platform zone during the MWM 
reversal test, which indicates enhanced re-learning ability compared to the 
CTL mice.  
Since the MWM test has been related with hippocampal LTP as well as 
NMDA receptor function (Morris et al., 1986; Bannerman et al., 1995), we 
harvested the hippocampi of mice subjected to behavior and did 




postsynaptic density proteins including Prr7. There was a significant 
increase was in Prr7 levels, which supports the role of Prr7 in memory 
enhancement. These findings also correlated with the changes of neuronal 
morphology regarding dendritic spine phenotype found in the CA1 region 
related with spatial memory, indicating a significant contribution of CA1 
pyramidal neuron morphology to the circuitry for learning and memory 
(Tsien et al., 1996). Behavioral improvement in learning and memory in the 
neuron specific N4-2 mice provided novel insights into the molecular 
machinery of learning and memory.  
 
 
4.4 Neuronal N4-2 as a regulator for L-LTP 
Dendritic spines are small protrusions that form synaptic contacts 
with presynaptic boutons. There are huge varieties in the size and shape of 
spines. The morphology as well as the number of spines can be modified in 
response to the intensity and the number of afferent inputs. Spines are not 
commonly present in lower organisms such as Drosophila melanogaster 
and Caenorhabditis elegans, indicating that they might have evolved to 
process more complex information in the mammalian brain (Hering & 
Sheng, 2001; Puram & Bonni, 2013; Sala & Segal, 2014). Spine head size 
correlates with the PSD size and also with vesicular pool size of its 
corresponding presynaptic bouton, which can lead to changes in synaptic 
transmission (Harris & Stevens, 1989). Spine length, on the other hand, 
could affect the calcium distribution in the spine, and its increase can lead to 
a decrease in postsynaptic activation (Volfovsky et al., 1999; Araya et al., 
2014). These changes could also modify electrophysiological characteristics 
of postsynaptic neurons, e.g. enlargement of spine heads results in 
stabilization of synapses harboring increased glutamate receptors (Fiala et 
al., 2002; Comery et al., 1997; Noguchi et al., 2005). Considering that Prr7 
interacts with NMDA receptor subunits (Murata et al., 2005) and that Prr7 is 
accumulated on tip of spines (Figure 3.6), N4-2 might control the distribution 




significant changes in total and cell surface levels of glutamate receptor 
subunits such as GluN1, GluN2B, GluA1, and GluA2 in the absence of N4-2 
(Figures 3.14 and 3.15). 
Trommald and colleagues proposed a link between LTP and bifurcated 
spines by demonstrating an increase in bifurcated spines upon LTP 
induction (Trommald et al, 1996). However, involvement of bifurcated spines 
in memory formation and the molecular machinery of spine bifurcation are 
still unclear. Our morphometric analyses of spines demonstrate the critical 
role of N4-2 in spine bifurcation (Figure 5.3). The increased number of 
bifurcated spines observed in N4-2 KO mice might play a role in the 
maintenance of L-LTP. Indeed, we observed enhanced L-LTP in N4-2 KO 
mice, whereas there was no change in E-LTP or LTD, which supports our 
findings in increased learning and memory. Moreover, the change in L-LTP 
between the N42 KO and CTL was reversed by deleting one allele of Prr7, 
indicating that upregulation of Prr7 is the cause of enhanced L-LTP in N4-2 
KO mice  (Figure 3.17 C).  
 
 
4.5. Roles of N4-2 in neuronal apoptosis 
It was recently reported that Prr7 shuttles from the postsynapse to the 
nucleus to mediate excitotoxicity upon the stimulation of NMDA receptors 
(Kravchick et al., 2016). This process is required for the blockade of 
ubiquitination and proteasomal degradation of phospho-c-jun to promote 
neuronal death. Unexpectedly, our live imaging experiment resulted in 
neuroprotection upon the loss of neuronal N4-2. This result indicates that an 
alternative substrate of N4-2 is involved in the control of excitotoxicity in a 
cell autonomous manner.  Interestingly, we identified Cxn-43 as a substrate 
of N4-2 and the protein level of Cnx-43 is increased in the absence of N4-2 
in glial cells (Figure 5.4). Cnx-43 is dominantly expressed in the astrocyte 
and the glia cell-specific conditional deletion of Cnx-43 results in enlarged 
infarct volume after middle cerebral artery (MCA) occlusion and reperfusion 




ischemic stroke, which is mediated by NMDA-dependent excitotoxicity. 
Overall, we hypothesize that the loss of N4-2 in neurons leads to an 
increase in an unknown substrate resulting in neuroprotection, while its loss 
in astrocytes results in an increase in Cnx-43 level, which protects neurons 
from excitotoxicity in a non-cell autonomous manner.  
	
 
4.6. Multiple layers of regulation of Prr7 level 
MicroRNAs (miRNAs) are small noncoding RNAs that act by interfering with 
the stability or translation of messenger RNAs (mRNAs). miRNAs are widely 
expressed in eukaryotic cells, and regulate several genes involved in 
cellular processes like inflammation, cell-cycle regulation, stress response, 
differentiation, apoptosis, and migration via ribonuclease-based degradation 
system. Ubiquitination, on the other hand, is a regulatory mechanism at the 
protein level through the degradation of cellular proteins by the ubiquitin 
proteasome system. The miRNA and ubiquitination systems have 
similarities in several aspects; however, ubiquitination is a more robust and 
specific system, while miRNA regulates multiple targets mildly to move the 
molecular balance to change a certain cell function (e.g. synaptogenesis) 
(Di Leva et al., 2014; Gebert & MacRae, 2019). 
Very recently, Prr7 protein levels were reported to be upregulated in the 
hippocampus of miR379-410 KO mice (Lackinger et al., 2019). They 
demonstrated that miR379-410 KO mice show hypersocial behavior 
together with increased excitatory neurotransmission and spine density, 
which partially goes in line with our findings of increased L-LTP and altered 
spine morphology, revealing another level of regulation of Prr7 in neurons. 








4.7. Summary  
In the present study, Neuronal N4-2 is characterized as the E3 ligase for the 
regulation of Prr7 protein level. It has been further confirmed by 
demonstrating increased surface expression of Prr7 in N4-2 KO neurons, 
ubiquitination assays, and binding assays that N4-2 binds and ubiquitinates 
Prr7. Prr7 is found to be at the tip of the spine in vivo, and the morphological 
analysis of N4-2 KO mice demonstrating that N4-2 E3 ligase has a role in 
spine formation. Moreover, N4-2 KO mice showed improved memory 
formation and re-learning ability, as well as increased L-LTP; and this effect 
is rescued by N4-2 KO;Prr7 heterozygous mice, stating that Prr7 is 
responsible for this phenotype. All in all, this study provides a novel role of 





























Figure 5.1. Prr7 levels in N4-1 and N4-2 conditional KO mouse lines. (A) 
Protein levels of Prr7 in cortical brain lysates from 6 weeks old N4-1/2 CTL 
(Emx1 WT) and N4-1/2 bDKO (Emx1 Cre) animals. For the statistical 
analyses, Prr7 level was normalized to tubulin level. Prr7 protein showed a 
significant increase (N4-1/2 bCTL 1.00 ± 0.078, N=3; N4-1/2 bDKO, 2.18 ± 
0.13, N=3; p=0.0014 (B) Prr7 protein levels in N4-1/2 CTL (Nex WT) and 
N4-1/2 nDKO (Nex Cre) cortical homogenates (N4-1/2 CTL 1.00 ± 0.082, 
N=3; N4-1/2 nDKO, 2.45 ± 0.085, N=3; p= 0.0003). Note that the fold 




























































































































































































































































































































































































































































































































































Prr7 levels in N4-1 CTL (Emx1 WT) and N4-1 bKO (Emx1 Cre) cortical 
homogenates (N4-1 CTL, 1.000 ± 0.122 N=4; N4-1 bKO, 0.77 ± 0.102, N=4; 
p= 0.2011). (D) Prr7 levels in N4-2 CTL (Emx1 WT) and N4-2 bKO (Emx1 
Cre) cortical homogenates (N4-2 CTL 1.000 ± 0.127, N=3; N4-2 bKO, 1.94 ± 
0.072, N=3; p= 0.0030). Represented as mean ± SEM. (Modified from Altas, 






Figure 5.2 In vitro and in vivo ubiquitination of Prr7 by N4-2. (A) In vitro 
ubiquitination assay was performed with Myc-tagged cytoplasmic region of 
Prr7 (Myc-Prr7 Cyt), ATP, recombinant ubiquitin, and E1 enzyme in the 
presence or absence of E2, N4-1, and N4-2. Ubiquitination was detected by 
the shift of molecular weight of Myc-Prr7 Cyt with anti-Myc antibody. Note 
the increase in the molecular weight of Myc-Prr7 Cyt at the expense of 
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and N4-2. (B) FLAG-tagged Prr7 (Prr7-FLAG) was expressed in HEK293FT 
cells with or without EGFP-N4-1 or -N4-2. Immunoprecipitates using an anti-
FLAG antibody-coupled agarose beads were subjected to Western blotting 
using anti-FLAG (second panel) or anti-Ub antibody (third panel). Samples 
were blotted with anti-K48-linked polyUb (K48; fourth panel) or anti-K63-
linked polyUb (K63; fifth panel) antibodies. Note that signals from K48-linked 





Figure 5.3. Spine analysis in neuron-specific N4-2 conditional KO 
mouse. (A) In situ hybridization using probes against N4-2 mRNA on 
sagittal sections in P20 murine brain and control reaction with sense probe 
(Figure A, bottom left). Note that dark signals show strong hybridization. 




olfactory bulb (ob), Cornu Ammonis area 1 CA1, dentate gyrus (DG). N4-2 
mRNA levels are elevated in CA1 and DG of hippocampus (Figure A, 
enlarged square). (B) Representative maximum projections images of anti-
GFP labeled dendrites of control (Nedd4-2f/f, left panel) and neuron-specific 
N4-2 knockout (Nedd4-2f/f;NEX-Cre+/-, right panel) CA1 neurons. (C) Spine 
number quantification in control and N4-2 KO dendrites. (D) Spine length 
quantification in control and N4-2 KO (filopodia: N4-2 CTL, 0.88 ± 0.24 µm; 
N4-2 KO, 1.26 ± 0.28 µm, thin: N4-2 CTL, 0.92 ± 0.19 µm; N4-2 KO, 1.19 ± 
0.24 µm, mushroom: N4-2 CTL, 0.80 ± 0.16 µm; N4-2 KO, 1.00 ± 0.26 µm). 
* p < 0.05, *** p < 0.001, unpaired t-test. (E) Head diameter measurement in 
control and N4-2 KO neurons (thin: N4-2 CTL 0.35 ± 0.07 µm; N4-2 KO, 
0.43 ± 0.09 µm). * p < 0.05, unpaired t-test. (F) Fraction of total spines 
showing significant decrease in mushroom spines, and increase in 
bifurcated spines (mushroom: N4-2 CTL 0.20 ± 0.06; N4-2 KO 0.11 ± 0.06, 
bifurcated: N4-2 CTL 0.03 ± 0.03; N4-2 KO 0.07 ± 0.04). Two way ANOVA 
with Bonferroni multiple comparisons test; * p < 0.05. Bars represent 
averages ± S.D. C, N4-2 CTL N = 2 animals, n = 11 cells, n = 288 spines; 
N4-2 KO, N = 2 animals, n = 12 cells, n = 315 spines (Ambrozkiewicz, 2015, 


















Figure 5.4. Cnx-43 levels in N4-1 and N4-2 conditional KO mouse lines. 
(A) Protein levels of Cnx-43 in cortical brain lysates from 6 weeks old N4-1/2 
CTL (Emx1 WT) and N4-1/2 bDKO (Emx1 Cre) animals. Cnx-43 level was 
normalized to tubulin level. Cnx-43 protein showed a significant increase in 
N4-1/2 bDKO (A) N4-1/2 bCTL, 1.00 ± 0.035, N=3; N4-1/2 bDKO, 1.95 ± 
0.16 N=3; p= 0.0044 (B) Unchanged Cnx-43 protein levels in N4-1/2 CTL 
(Nex WT) and N4-1/2 nDKO cortical homogenates (N4-1/2 nCTL 1.00 ± 
0.012, N=3; N4-1/2 nDKO, 1.051 ± 0.040, N=3; p= 0.2927). (C) Cnx-43 
levels in N4-1 CTL (Emx1 WT) and N4-1 bKO (Emx1 Cre) cortical 
homogenates (N4-1 bCTL, 1.00 ± 0.13, N=4; N4-1 bKO, 0.82 ± 0.029, N=4; 
p= 0.2382). (D) Cnx-43 levels in N4-2 CTL (Emx1 WT) and N4-2 bKO 




























































































































































































































































































































































































































































































































































1.55 ± 0.068, N=3; p= 0.0193). Represented as mean ± SEM. (Modified 







Figure 5.5. In vivo ubiquitination assay for Cnx-43 and Nedd4 E3s. C-
terminally HA-tagged Connexin-43 (Connexin-43-HA or Cnx-43-HA) was 
expressed in HEK293FT cells in the presence or absence of EGFP-N4-1 or 
-N4-2. Immunoprecipitates were subjected to Western blotting using anti-HA 
(second panel) or anti-Ub antibody (third panel). Samples were blotted with 
anti-K48-linked polyUb (K48; fourth panel) or anti-K63-linked polyUb (K63; 
fifth panel) antibodies. Note the comparable signals from K48-linked 
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